ๆญฃๅœจๅŠ ่ฝฝ่ง†้ข‘...

่ง†้ข‘ๅŠ ่ฝฝๅคฑ่ดฅ

It's disappointing to see the ๐—•๐—๐—ฃ ๐— ๐—ฃ ๐—ฎ๐—ป๐—ฑ ๐—จ๐—ป๐—ถ๐—ผ๐—ป ๐— ๐—ถ๐—ป๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐˜๐˜๐—ฒ๐—บ๐—ฝ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฐ๐—น๐—ฎ๐—ถ๐—บ ๐—ฐ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐˜ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐— ๐—ถ๐˜๐—ต ๐—–๐—ต๐—ผ๐˜„๐—ธ๐˜† ๐—ณ๐—น๐˜†๐—ผ๐˜ƒ๐—ฒ๐—ฟ. Let's get the facts straight: from day one, we led the charge for this project, navigating countless bureaucratic hurdles and delays. We took on the tough work, consistently pushing authorities...

42,192 ๆฌก่ง‚็œ‹ โ€ข 2 ๅนดๅ‰ โ€ขvia X (Twitter)

10 ๆก่ฏ„่ฎบ

ProudIndian๐Ÿ‡ฎ๐Ÿ‡ณ ็š„ๅคดๅƒ
ProudIndian๐Ÿ‡ฎ๐Ÿ‡ณ2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority เค…เคธเคฒเฅ€ เคนเฅ€เคฐเฅ‹ เค…เคธเคฒเฅ€ เคจเฅ‡เคคเคพ เค…เคธเคฒเฅ€ เคชเคพเคฐเฅเคŸเฅ€ เค•เคพเค‚เค—เฅเคฐเฅ‡เคธ เคชเคพเคฐเฅเคŸเฅ€ เคœเคฟเค‚เคฆเคพเคฌเคพเคฆ เคเค•เคฆเคฎ เค•เคกเคผเค• เคกเฅˆเคถเคฟเค‚เค— เค†เคฎเคฆเคพเคฐ เค…เคธเคฒเคฎ เคถเฅ‡เค–

P r /\ T | k ็š„ๅคดๅƒ
P r /\ T | k2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Sir, everyone is aware as to due to whose efforts this Mithchowky Flyover was possible, now please get rid off all the illegal hoardings everywhere!!

belive ็š„ๅคดๅƒ
belive2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Thank you for hard work & determination Mr.Aslam Shaikh

Fight against unethical practice ็š„ๅคดๅƒ
Fight against unethical practice2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Therefore u r termed as most dashing MLA

เคฏเฅ‹เคฆเฅเคงเคพ ็š„ๅคดๅƒ
เคฏเฅ‹เคฆเฅเคงเคพ2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority @AslamShaikh_MLA เคฏเคพเค‚เคšเฅเคฏเคพเคถเฅ€ เคฎเฅ€ เคชเฅ‚เคฐเฅเคฃเคชเคฃเฅ‡ เคธเคนเคฎเคค เค†เคนเฅ‡, เคญเคพเคœเคช เคจเฅ‡เคคเฅ‡ เค…เคจเคพเคตเคถเฅเคฏเค• เคถเฅเคฐเฅ‡เคฏ เค˜เฅ‡เคค เค†เคนเฅ‡เคค. I totally agree with @AslamShaikh_MLA , BJP leaders are taking unnecessary credit.

Tarannum khan ๐Ÿ‡ฎ๐Ÿ‡ณ ็š„ๅคดๅƒ
Tarannum khan ๐Ÿ‡ฎ๐Ÿ‡ณ2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Yes ...It is necessary to expose the false leaders of cunning BJ party Proud of you The Lion @AslamShaikh_MLA ji โœŒ๏ธ team @RahulGandhi ji ๐Ÿ’—

Pathan Sikander ็š„ๅคดๅƒ
Pathan Sikander2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Dhannewad aamder saheb

AndheriInfra ็š„ๅคดๅƒ
AndheriInfra2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Every one knows it was your initiative. Chill.

Bharat Soni ็š„ๅคดๅƒ
Bharat Soni2 ๅนดๅ‰

Bhai Electorates of the area know that it's @AslamShaikh_MLA efforts. They have inborn qualities of claiming a credit for work not initiated by them nor done by them. We should have defeated him by offering the seat to Shivsena UBT's Tejashree Ghosalkar. Now we have to tolerate him.

P r /\ T | k ็š„ๅคดๅƒ
P r /\ T | k2 ๅนดๅ‰

@INCIndia @RahulGandhi @kharge @priyankagandhi @kcvenugopalmp @VarshaEGaikwad @chennithala @INCMumbai @ShayarImran @INCMinority Substantial reduction in traffic today i.e. Monday Morning at Marve rd Mithchowky! Eagerly awaiting for the Link rd arm to be completed by December! Now Plz do something about the Jankalyan Nagar-Charkop rd through Bhoomi Park as that will decongest Oscar Hospital junction!

็›ธๅ…ณ่ง†้ข‘

๐—ฆ๐—ผ๐—บ๐—ฒ ๐—บ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ๐˜€ ๐—ฑ๐—ฒ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ฒ ๐˜๐—ผ ๐—ฏ๐—ฒ ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฏ๐—ฟ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ผ๐—ป ๐—ฎ ๐—ด๐—ฟ๐—ฎ๐—ป๐—ฑ๐—ฒ๐—ฟ ๐˜€๐—ฐ๐—ฎ๐—น๐—ฒ. โœจ ๐—ง๐—ผ๐—บ๐—ผ๐—ฟ๐—ฟ๐—ผ๐˜„, ๐˜„๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ๐—น๐˜† ๐˜‚๐—ป๐˜ƒ๐—ฒ๐—ถ๐—น ๐˜๐—ต๐—ฟ๐—ฒ๐—ฒ ๐—Ÿ๐—˜๐—— ๐—ฏ๐—ถ๐—น๐—น๐—ฏ๐—ผ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ฑ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฏ๐—ฟ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—ž๐—ฟ๐˜†๐˜€๐˜๐—ฎ๐—น ๐— ๐—ฒ๐—ท๐—ฒ๐˜€' ๐Ÿญ๐Ÿด๐˜๐—ต ๐—ฏ๐—ถ๐—ฟ๐˜๐—ต๐—ฑ๐—ฎ๐˜†โ€”a heartfelt tribute made possible by the love, generosity, and collective effort of everyone who helped bring this project to life. ๐Ÿค ๐—ง๐—ต๐—ถ๐˜€ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ๐—ป'๐˜ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฝ๐—ผ๐˜€๐˜€๐—ถ๐—ฏ๐—น๐—ฒ ๐˜„๐—ถ๐˜๐—ต๐—ผ๐˜‚๐˜ ๐˜๐—ต๐—ฒ ๐˜‚๐—ป๐˜„๐—ฎ๐˜ƒ๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ผ๐—ณ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ง๐—ฎ๐—น๐—ถ๐—ฎ๐—ป ๐˜„๐—ต๐—ผ ๐—ฏ๐—ฒ๐—น๐—ถ๐—ฒ๐˜ƒ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐˜‚๐˜€. Thank you for every donation, every share, and every act of support. ๐—ง๐—ต๐—ถ๐˜€ ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฏ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฏ๐—ฒ๐—น๐—ผ๐—ป๐—ด๐˜€ ๐˜๐—ผ ๐—ฎ๐—น๐—น ๐—ผ๐—ณ ๐˜‚๐˜€. ๐—™๐—ผ๐—ฟ ๐—ป๐—ผ๐˜„, ๐—ฒ๐—ป๐—ท๐—ผ๐˜† ๐˜๐—ต๐—ถ๐˜€ ๐˜๐—ฒ๐—ฎ๐˜€๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐˜„๐—ต๐—ฎ๐˜'๐˜€ ๐˜„๐—ฎ๐—ถ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฏ๐—ฒ ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ฎ๐—น๐—ฒ๐—ฑ. Special thanks to pb .แŸ ๐—ฎ๐—ป๐—ฑ yj ๐—ณ๐—ผ๐—ฟ ๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ถ๐˜€ ๐—ฏ๐—ฒ๐—ฎ๐˜‚๐˜๐—ถ๐—ณ๐˜‚๐—น ๐˜๐—ฒ๐—ฎ๐˜€๐—ฒ๐—ฟ and ๐—ต๐—ฒ๐—น๐—ฝ๐—ถ๐—ป๐—ด ๐˜‚๐˜€ ๐—ฏ๐—ฟ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜ ๐˜๐—ผ ๐—น๐—ถ๐—ณ๐—ฒ. โœจ ๐—ฆ๐—ฒ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐˜๐—ผ๐—บ๐—ผ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ฎ๐˜€ ๐˜„๐—ฒ ๐—น๐—ถ๐—ด๐—ต๐˜ ๐˜‚๐—ฝ ๐—ž๐—ฟ๐˜†๐˜€๐˜๐—ฎ๐—น'๐˜€ ๐Ÿญ๐Ÿด๐˜๐—ต ๐—•๐—ถ๐—ฟ๐˜๐—ต๐—ฑ๐—ฎ๐˜†. โœจ #KrystalMejes #TALA18D11

TEAM KRYSTAL OFFICIAL

13,714 ๆฌก่ง‚็œ‹ โ€ข 2 ไธชๆœˆๅ‰

๐—˜๐—ถ๐—ด๐—ต๐˜๐—ฒ๐—ฒ๐—ป ๐˜†๐—ฒ๐—ฎ๐—ฟ๐˜€ ๐—ฎ๐—ด๐—ผ, a little girl began writing a story she never knew would touch so many lives. Today, ๐˜„๐—ฒ ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฏ๐—ฟ๐—ฎ๐˜๐—ฒ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฝ๐—ฎ๐—ด๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฎ๐˜ ๐˜€๐˜๐—ผ๐—ฟ๐˜†. From the little girl whose smile could brighten any room, to the young woman who continues to inspire through her ๐˜๐—ฎ๐—น๐—ฒ๐—ป๐˜, ๐—ฑ๐—ฒ๐˜๐—ฒ๐—ฟ๐—บ๐—ถ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป, ๐—ฎ๐—ป๐—ฑ ๐—ด๐—ฒ๐—ป๐˜‚๐—ถ๐—ป๐—ฒ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜โ€”you have grown into someone ๐˜„๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ฒ๐—ป๐—ฑ๐—น๐—ฒ๐˜€๐˜€๐—น๐˜† ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐—ผ๐—ณ. This video is more than a collection of clips. ๐—œ๐˜ ๐—ถ๐˜€ ๐—ฎ ๐—ท๐—ผ๐˜‚๐—ฟ๐—ป๐—ฒ๐˜† ๐˜๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฐ๐—ต๐—ฎ๐—ฝ๐˜๐—ฒ๐—ฟ ๐˜๐—ต๐—ฎ๐˜ ๐˜€๐—ต๐—ฎ๐—ฝ๐—ฒ๐—ฑ ๐˜†๐—ผ๐˜‚. The childhood memories, the first steps toward your dreams, the projects that introduced you to the world, the milestones you worked so hard to achieve, the victories worth celebrating, and the countless moments that revealed ๐˜๐—ต๐—ฒ ๐—ธ๐—ถ๐—ป๐—ฑ ๐—ผ๐—ณ ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป ๐˜†๐—ผ๐˜‚ ๐˜๐—ฟ๐˜‚๐—น๐˜† ๐—ฎ๐—ฟ๐—ฒ. Behind every achievement is ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ฒ. Behind every role is ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฝ๐—ฎ๐˜€๐˜€๐—ถ๐—ผ๐—ป. And behind every success is ๐˜๐—ต๐—ฒ ๐˜€๐—ฎ๐—บ๐—ฒ ๐—ต๐˜‚๐—บ๐—ฏ๐—น๐—ฒ, ๐—ธ๐—ถ๐—ป๐—ฑ-๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฑ ๐—ž๐—ฟ๐˜†๐˜€๐˜๐—ฎ๐—น who has never forgotten to make people feel seen and loved. ๐—ง๐—ต๐—ฎ๐—ป๐—ธ ๐˜†๐—ผ๐˜‚ ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—น๐—น๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐˜‚๐˜€ ๐˜๐—ผ ๐˜„๐—ถ๐˜๐—ป๐—ฒ๐˜€๐˜€ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ด๐—ฟ๐—ผ๐˜„๐˜๐—ตโ€”not only as an artist, but as a person. Watching you chase your dreams has inspired us to believe in our own, and watching you remain genuine through it all has made us ๐—ฎ๐—ฑ๐—บ๐—ถ๐—ฟ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐—บ๐—ผ๐—ฟ๐—ฒ. As you turn eighteen, we hope you continue to embrace ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ผ๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜‚๐—ป๐—ถ๐˜๐˜†, ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—น๐—ฒ๐˜€๐˜€๐—ผ๐—ป, ๐—ฎ๐—ป๐—ฑ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฑ๐—ฟ๐—ฒ๐—ฎ๐—บ waiting to be fulfilled. May this new chapter be filled with ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐—ด๐—ฟ๐—ฒ๐—ฎ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐˜€๐—ต๐—บ๐—ฒ๐—ป๐˜๐˜€, ๐˜‚๐—ป๐—ณ๐—ผ๐—ฟ๐—ด๐—ฒ๐˜๐˜๐—ฎ๐—ฏ๐—น๐—ฒ ๐—บ๐—ฒ๐—บ๐—ผ๐—ฟ๐—ถ๐—ฒ๐˜€, ๐—ฎ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐—ต๐—ฎ๐—ฝ๐—ฝ๐—ถ๐—ป๐—ฒ๐˜€๐˜€ ๐˜†๐—ผ๐˜‚ ๐—ฑ๐—ฒ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ฒ. ๐—ง๐—ต๐—ฒ ๐—น๐—ถ๐˜๐˜๐—น๐—ฒ ๐—ด๐—ถ๐—ฟ๐—น ๐˜„๐—ต๐—ผ ๐—ผ๐—ป๐—ฐ๐—ฒ ๐—ฑ๐—ฟ๐—ฒ๐—ฎ๐—บ๐—ฒ๐—ฑ ๐—ต๐—ฎ๐˜€ ๐—ฏ๐—ฒ๐—ฐ๐—ผ๐—บ๐—ฒ ๐—ฎ ๐˜†๐—ผ๐˜‚๐—ป๐—ด ๐˜„๐—ผ๐—บ๐—ฎ๐—ป ๐˜„๐—ถ๐˜๐—ต ๐˜๐—ต๐—ฒ ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ ๐˜๐—ผ ๐—ถ๐—ป๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฒ ๐˜๐—ต๐—ผ๐˜‚๐˜€๐—ฎ๐—ป๐—ฑ๐˜€โ€”and ๐˜๐—ต๐—ถ๐˜€ ๐—ถ๐˜€ ๐—ผ๐—ป๐—น๐˜† ๐˜๐—ต๐—ฒ ๐—ฏ๐—ฒ๐—ด๐—ถ๐—ป๐—ป๐—ถ๐—ป๐—ด ๐—ผ๐—ณ ๐—ฎ๐—ป ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—ฏ๐—ฒ๐—ฎ๐˜‚๐˜๐—ถ๐—ณ๐˜‚๐—น ๐—ท๐—ผ๐˜‚๐—ฟ๐—ป๐—ฒ๐˜†. ๐—›๐—ฎ๐—ฝ๐—ฝ๐˜† ๐Ÿญ๐Ÿด๐˜๐—ต ๐—•๐—ถ๐—ฟ๐˜๐—ต๐—ฑ๐—ฎ๐˜†, ๐—ž๐—ฟ๐˜†๐˜€๐˜๐—ฎ๐—น. ๐Ÿค ๐—ง๐—ต๐—ฎ๐—ป๐—ธ ๐˜†๐—ผ๐˜‚ ๐—ณ๐—ผ๐—ฟ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—บ๐—ฒ๐—บ๐—ผ๐—ฟ๐˜† ๐˜†๐—ผ๐˜‚'๐˜ƒ๐—ฒ ๐—ด๐—ถ๐˜ƒ๐—ฒ๐—ป ๐˜‚๐˜€. Here's to celebrating ๐—ฎ๐—น๐—น ๐˜๐—ต๐—ฎ๐˜ ๐˜†๐—ผ๐˜‚'๐˜ƒ๐—ฒ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐˜€๐—ต๐—ฒ๐—ฑ, and to ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ถ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐—ฏ๐—น๐—ฒ ๐—ฐ๐—ต๐—ฎ๐—ฝ๐˜๐—ฒ๐—ฟ ๐˜๐—ต๐—ฎ๐˜ ๐—ถ๐˜€ ๐˜€๐˜๐—ถ๐—น๐—น ๐˜„๐—ฎ๐—ถ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฏ๐—ฒ ๐˜„๐—ฟ๐—ถ๐˜๐˜๐—ฒ๐—ป. ๐—ช๐—ถ๐˜๐—ต ๐—ฎ๐—น๐—น ๐—ผ๐˜‚๐—ฟ ๐—น๐—ผ๐˜ƒ๐—ฒ, ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—ง๐—ฎ๐—น๐—ถ๐—ฎ๐—ป๐˜€. ๐Ÿค KRYSTAL MEJES TURNS EIGHTEEN #TALA18DDAY

TEAM KRYSTAL OFFICIAL

47,052 ๆฌก่ง‚็œ‹ โ€ข 2 ไธชๆœˆๅ‰

#๐——๐—ฒ๐—ฃ๐—ถ๐—ป We are proud that #๐—”๐˜๐—น๐—ฎ๐˜€๐—ก๐—ฎ๐˜ƒ๐—ถ has been featured in the Messari's report on bullish #DePin crypto projects for 2024: $NAVI โžž Blockchain based navigation with Drive-to-Earn implementation. #๐—š๐—ฟ๐—ฎ๐—ป๐˜๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฎ๐—ป๐—จ๐—ป๐—ถ๐—ผ๐—ป We accessed a grant from the ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฎ๐—ป ๐—จ๐—ป๐—ถ๐—ผ๐—ป back in 2020. โœจ#DePin 2024 โœจPart of the ๐—˜๐—จ๐—ฅ๐—ข๐—ฃ๐—˜๐—”๐—ก ๐—จ๐—ก๐—œ๐—ข๐—กโ€™๐˜€ โ€œ๐—”.๐—œ. ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—š๐—ฟ๐—ฎ๐—ป๐˜โ€ program 2020. โœจ๐—˜๐—จ ๐—˜๐—ซ๐—ฃ๐—˜๐—ฅ๐—ง ๐—”๐——๐—ฉ๐—œ๐—ฆ๐—ข๐—ฅ in the ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฎ๐—ป ๐—–๐—ผ๐—บ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป for transportation, smart-city and connected vehicles legislation. โœจ Over ten years of international experience developing commercial mobility applications. โœจ๐—ง๐—ต๐—ฒ ๐—™๐—ถ๐—ฟ๐˜€๐˜ ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ-๐—ง๐—ผ-๐—˜๐—ฎ๐—ฟ๐—ป ๐—”.๐—œ. ๐—ก๐—ฎ๐˜ƒ๐—ถ๐—ด๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—”๐—ฝ๐—ฝ. โœจ ๐—”๐˜๐—น๐—ฎ๐˜€ ๐—ก๐—ฎ๐˜ƒ๐—ถ ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—ฏ๐—ฎ๐—ฏ๐—น๐˜† ๐—ฎ๐—บ๐—ผ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐˜๐—ผ๐—ฝ ๐Ÿฌ.๐Ÿญ% ๐—ผ๐—ณ ๐—ฝ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜๐˜€ ๐˜๐—ผ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—น-๐—น๐—ถ๐—ณ๐—ฒ ๐˜‚๐˜๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฒ๐—ป๐—ฎ๐—ฏ๐—น๐—ถ๐—ป๐—ด ๐˜‚๐˜€๐—ฒ๐—ฟ๐˜€ ๐˜๐—ผ ๐—ฝ๐—ฎ๐˜† ๐˜„๐—ถ๐˜๐—ต $๐—ก๐—”๐—ฉ๐—œ ๐—ฎ๐˜ ๐—ต๐˜‚๐—ป๐—ฑ๐—ฟ๐—ฒ๐—ฑ๐˜€ ๐—ผ๐—ณ ๐—น๐—ผ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ผ๐˜‚๐—ฟ ๐—ฎ๐˜‚๐˜๐—ผ๐—บ๐—ผ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฝ๐—ฎ๐—ฟ๐˜๐—ป๐—ฒ๐—ฟ๐˜€ (๐—ด๐—ฎ๐˜€ ๐˜€๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€, ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฐ๐—ฒ ๐—น๐—ผ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ผ๐—ฟ๐—ฒ) โœจ ๐—”๐˜๐—น๐—ฎ๐˜€ ๐—ก๐—ฎ๐˜ƒ๐—ถ ๐—ถ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐˜๐—ผ๐—ฝ ๐Ÿฌ.๐Ÿญ% ๐—ผ๐—ณ ๐—ฝ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜๐˜€ ๐˜๐—ผ ๐—น๐—ถ๐˜€๐˜ ๐—ผ๐—ป ๐—ฎ๐—ป ๐—ฒ๐˜…๐—ฐ๐—ต๐—ฎ๐—ป๐—ด๐—ฒ ๐—”๐—™๐—ง๐—˜๐—ฅ ๐—ฑ๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฎ ๐˜„๐—ผ๐—ฟ๐—ธ๐—ถ๐—ป๐—ด ๐—”.๐—œ. ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ ๐—ฎ๐—ป๐—ฑ ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐Ÿญ๐Ÿฌ๐Ÿฌ,๐Ÿฌ๐Ÿฌ๐Ÿฌ ๐˜‚๐˜€๐—ฒ๐—ฟ๐˜€. โœจ๐—›๐˜‚๐—ด๐—ฒ ๐—ฃ๐—ฎ๐—ฟ๐˜๐—ป๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ๐˜€ #๐—”๐˜๐—น๐—ฎ๐˜€๐—ก๐—ฎ๐˜ƒ๐—ถ ๐˜„๐—ถ๐—น๐—น ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐˜๐—ผ ๐—ด๐—ฟ๐—ผ๐˜„ ๐—ฎ๐—ป๐—ฑ ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—น-๐—น๐—ถ๐—ณ๐—ฒ ๐—จ๐—ง๐—œ๐—Ÿ๐—œ๐—ง๐—ฌ ๐—ณ๐—ผ๐—ฟ ๐—ถ๐˜๐˜€ ๐˜‚๐˜€๐—ฒ๐—ฟ๐˜€. Stay tuned! More to come! #๐—”๐˜๐—น๐—ฎ๐˜€๐—ก๐—ฎ๐˜ƒ๐—ถ #๐——๐—ฒ๐—ฃ๐—ถ๐—ป #DriveToEarn #web3 #crypto

ATLAS NAVI | AI Navigation APP with 1M Downloads

44,084 ๆฌก่ง‚็œ‹ โ€ข 2 ๅนดๅ‰

๐—œ๐˜โ€™๐˜€ ๐˜๐—ถ๐—บ๐—ฒ ๐˜„๐—ฒ ๐—บ๐—ผ๐˜ƒ๐—ฒ๐—ฑ ๐—ผ๐—ปโ€ฆ.. (final thoughts on the controversy) When will we move beyond the ๐˜๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ฎ๐—น ๐—ป๐—ผ๐˜๐—ถ๐—ผ๐—ป & ๐—ฝ๐—ฒ๐˜๐˜๐˜† ๐—บ๐—ถ๐—ป๐—ฑ๐˜€๐—ฒ๐˜ ๐˜๐—ต๐—ฎ๐˜ ๐—ฎ ๐—ฝ๐—ถ๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ ๐—ต๐—ฎ๐˜€ ๐—ป๐—ผ ๐—ฟ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐˜๐—ผ ๐—ผ๐—ป๐—ฒ'๐˜€ ๐—ฏ๐—ฒ๐—น๐—ถ๐—ฒ๐—ณ๐˜€? (Take a look at those in the video). When will we begin ๐—ฒ๐—ป๐—ด๐—ฎ๐—ด๐—ถ๐—ป๐—ด ๐˜„๐—ถ๐˜๐—ต ๐—ฝ๐—ฒ๐—ผ๐—ฝ๐—น๐—ฒ ๐—ผ๐—ณ ๐—ฑ๐—ถ๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐˜ ๐˜๐—ต๐—ฒ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฒ๐˜€ to arrive at conclusions that align with what is most pleasing to Allah? (Take a look at those in the video). ๐—ช๐—ต๐—ฒ๐—ป ๐—ฎ๐—ฟ๐—ฒ ๐˜„๐—ฒ ๐—ด๐—ผ๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐˜€๐˜๐—ฎ๐—ฟ๐˜ ๐˜„๐—ผ๐—ฟ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ผ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—บ๐—ถ๐—ป๐—ถ๐—บ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐˜๐—ฒ๐—ป๐˜€๐—ถ๐—ผ๐—ป๐˜€ between groups, so that we can focus on the greater enemy, especially in testing & challenging times like the one we are living in here in the west? (๐—”๐˜€ ๐—บ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—”๐—น๐—ฏ๐—ฎ๐—ป๐—ถ & others and of courseุŒ ๐—ป๐—ผ๐˜ undermining the continues importance of theology). When are we going to arrange conferences in the West, similar to the one in the video, ๐˜๐—ผ ๐—ฒ๐—ป๐—ด๐—ฎ๐—ด๐—ฒ ๐—ถ๐—ป ๐—ฑ๐—ถ๐˜€๐—ฐ๐˜‚๐˜€๐˜€๐—ถ๐—ผ๐—ป๐˜€ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐—ผ๐˜‚๐—ฟ ๐—ฑ๐—ถ๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€ so that the sincere can reach what is most pleasing to Allah? ๐—œ ๐˜„๐—ถ๐—น๐—น ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐—ฑ๐—ผ๐—ถ๐—ป๐—ด ๐˜„๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐˜€๐—ฐ๐—ต๐—ผ๐—น๐—ฎ๐—ฟ๐˜€ ๐—ฏ๐—ฒ๐—น๐—ผ๐˜„ (who have been slandered for years) have done and ๐˜„๐—ต๐—ฎ๐˜ ๐—œ๐—ฏ๐—ป ๐—ง๐—ฎ๐˜†๐—บ๐—ถ๐˜†๐˜†๐—ฎ๐—ต ๐—ฐ๐—ฎ๐—น๐—น๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ต๐—ถ๐˜€ ๐˜„๐—ต๐—ผ๐—น๐—ฒ ๐—น๐—ถ๐—ณ๐—ฒ, someone who hinged the concept of ๐—บ๐—ถ๐˜…๐—ถ๐—ป๐—ด/๐—ฑ๐—ฒ๐—ฏ๐—ฎ๐˜๐—ถ๐—ป๐—ด/๐˜€๐—ถ๐˜๐˜๐—ถ๐—ป๐—ด with those from different theologies to pros and cons. ๐—ง๐—ผ ๐—ฐ๐—ผ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ: The following was uttered by the shaykh of the Atharis in Aqeedah in modern day era, Shaykh Al-Alaama Abdallah Al Qunaiman: โ€œ๐—œ๐˜ ๐—ถ๐˜€ ๐—ฝ๐—ฒ๐—ฟ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ฏ๐—น๐—ฒ ๐˜๐—ผ ๐—ฑ๐—ฒ๐—ฎ๐—น ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—น๐—น๐—ฎ๐—ฏ๐—ผ๐—ฟ๐—ฎ๐˜๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐˜๐—ต๐—ฒ๐—บ ๐—ผ๐—ป ๐—ฟ๐—ถ๐—ด๐—ต๐˜๐—ฒ๐—ผ๐˜‚๐˜€๐—ป๐—ฒ๐˜€๐˜€, ๐—ด๐—ผ๐—ผ๐—ฑ ๐—ฑ๐—ฒ๐—ฒ๐—ฑ๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ถ๐—ฒ๐˜๐˜†. This is evident from the fact that Sheikh al-Islam Ibn Taymiyyah, ุฑุญู…ู‡ ุงู„ู„ู‡, ๐˜€๐˜๐˜‚๐—ฑ๐—ถ๐—ฒ๐—ฑ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—บ๐—ฎ๐—ป๐˜† ๐—”๐˜€๐—ต'๐—ฎ๐—ฟ๐—ถ ๐˜€๐—ฐ๐—ต๐—ผ๐—น๐—ฎ๐—ฟ๐˜€. ๐—œ๐—ป ๐—ณ๐—ฎ๐—ฐ๐˜, ๐—ต๐—ฒ ๐—ณ๐—ผ๐˜‚๐—ด๐—ต๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐˜๐—ต๐—ฒ ๐—ฏ๐—ฎ๐—ป๐—ป๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—บ๐—น๐˜‚๐—ธ ๐—ฟ๐˜‚๐—น๐—ฒ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฎ๐˜ ๐˜๐—ถ๐—บ๐—ฒ, the majority of whom were Ashโ€™ari. Furthermore, the heroic leader and martyr Nur ad-Din Zangi, as well as Salah ad-Din al-Ayyubi, were also Ash'ari, as stated by al-Dhahabi in his "Siyar A'lam al-Nubala." P.S. - ๐—œ ๐—ฑ๐—ผ๐—ปโ€™๐˜ ๐—ฎ๐—ด๐—ฟ๐—ฒ๐—ฒ with every detail and statement in this video; I shared it to highlight how many of the scholars today operate. Letโ€™s save the same energy.

MJ - Abu Taymiyyah

133,508 ๆฌก่ง‚็œ‹ โ€ข 2 ๅนดๅ‰

๐—ง๐—ต๐—ฒ ๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—บ๐—ฎ๐˜† ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ด๐—ผ๐—ป๐—ฒ ๐—ฑ๐—ผ๐˜„๐—ป, ๐—ฏ๐˜‚๐˜ ๐˜๐—ต๐—ฒ ๐—บ๐—ผ๐—บ๐—ฒ๐—ป๐˜ ๐˜„๐—ถ๐—น๐—น ๐˜€๐˜๐—ฎ๐˜† ๐˜„๐—ถ๐˜๐—ต ๐˜‚๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐—น๐—ผ๐—ป๐—ด ๐˜๐—ถ๐—บ๐—ฒ. โœจ๐Ÿ’Ž Yesterday was such a beautiful moment for all of us who have been cheering you on. Seeing you shine on that stage and witnessing this moment finally unfold was something we will always treasure. We hope you felt just how much you mean to the people who came together to celebrate you. ๐—ฌ๐—ผ๐˜‚ ๐—ฑ๐—ฒ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ฒ ๐˜๐—ผ ๐—ธ๐—ป๐—ผ๐˜„ ๐—ต๐—ผ๐˜„ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜„๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐˜†๐—ผ๐˜‚ and how many people will continue to cheer you on ๐—ฎ๐˜€ ๐˜†๐—ผ๐˜‚ ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐˜๐—ผ ๐—ด๐—ฟ๐—ผ๐˜„. ๐Ÿฉถ We hope yesterday becomes one of those memories you can look back on whenever you need a reminder of how loved and supported you are. ๐—ช๐—ต๐—ฎ๐˜๐—ฒ๐˜ƒ๐—ฒ๐—ฟ ๐—ฐ๐—ผ๐—บ๐—ฒ๐˜€ ๐—ป๐—ฒ๐˜…๐˜, ๐—ธ๐—ป๐—ผ๐˜„ ๐˜๐—ต๐—ฎ๐˜ ๐˜„๐—ฒโ€™๐—น๐—น ๐—ฏ๐—ฒ ๐—ต๐—ฒ๐—ฟ๐—ฒ ๐—ฐ๐—ต๐—ฒ๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐˜†๐—ผ๐˜‚ ๐—ผ๐—ป. ๐Ÿฅน ๐—ง๐—ผ ๐—ฎ๐—น๐—น ๐—ผ๐˜‚๐—ฟ ๐—ง๐—ฒ๐—ฎ๐—บ ๐—•๐—ฎ๐—ต๐—ฎ๐˜† ๐—ผ๐˜‚๐˜ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ, hereโ€™s the video we played during the event yesterday. We wanted to share this special moment with you, especially with those who couldnโ€™t be there in person. ๐—›๐—ฒ๐—ฟ๐—ฒโ€™๐˜€ ๐—ฎ ๐—ฝ๐—ถ๐—ฒ๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฎ๐˜ ๐—บ๐—ผ๐—บ๐—ฒ๐—ป๐˜ ๐˜๐—ผ ๐˜€๐—ต๐—ฎ๐—ฟ๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐˜†๐—ผ๐˜‚, ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฎ๐—น๐—น ๐—ผ๐—ณ ๐˜‚๐˜€ ๐˜„๐—ต๐—ผ ๐˜„๐—ฒ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ ๐˜†๐—ฒ๐˜€๐˜๐—ฒ๐—ฟ๐—ฑ๐—ฎ๐˜†. ๐—”๐—Ÿ๐—ช๐—”๐—ฌ๐—ฆ ๐—ฅ๐—˜๐— ๐—˜๐— ๐—•๐—˜๐—ฅ, ๐—ฌ๐—ข๐—จ ๐—”๐—ฅ๐—˜ ๐—ฆ๐—˜๐—˜๐—ก ๐—”๐—ก๐—— ๐—ฌ๐—ข๐—จ ๐—”๐—ฅ๐—˜ ๐—Ÿ๐—ข๐—ฉ๐—˜๐——. โœจ๐Ÿ’Ž KRYSTAL BECOMING BEGINS #BecomingKrystalMejes

TEAM KRYSTAL OFFICIAL

28,657 ๆฌก่ง‚็œ‹ โ€ข 10 ๅคฉๅ‰

More than 70,000 likes โค๏ธ on IG, yet 0 historical expertise. โ€ž๐—œ๐—ป ๐Ÿญ๐Ÿด๐Ÿด๐Ÿฐ ๐Ÿญ๐Ÿฐ ๐—ฐ๐—ผ๐˜‚๐—ป๐˜๐—ฟ๐—ถ๐—ฒ๐˜€ ๐—ฐ๐—ฎ๐—บ๐—ฒ ๐˜๐—ผ๐—ด๐—ฒ๐˜๐—ต๐—ฒ๐—ฟ ๐—ถ๐—ป ๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป๐˜† ๐˜๐—ผ ๐—ฑ๐—ถ๐˜ƒ๐—ถ๐—ฑ๐—ฒ ๐—”๐—ณ๐—ฟ๐—ถ๐—ฐ๐—ฎ ๐—น๐—ถ๐—ธ๐—ฒ ๐—ฎ ๐—ฝ๐—ถ๐—ฒ...โ€ โž” Not true. The conference merely set the legal and diplomatic rules for colonization rather than drawing every single border on the spot. โ€ž๐—ข๐˜๐˜๐—ผ ๐˜ƒ๐—ผ๐—ป ๐—•๐—ถ๐˜€๐—บ๐—ฎ๐—ฟ๐—ฐ๐—ธ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ ๐—ฐ๐—น๐—ฎ๐—ถ๐—บ ๐—ฎ ๐—ฝ๐—ผ๐—ฟ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฆ๐—ผ๐˜‚๐˜๐—ต๐˜„๐—ฒ๐˜€๐˜ ๐—”๐—ณ๐—ฟ๐—ถ๐—ฐ๐—ฎ ๐—ณ๐—ผ๐—ฟ ๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป๐˜†...โ€ โž” Bismarck did not just โ€žclaimโ€ this territory. He instructed the Cape government that the coastal territories acquired by Bremen merchant Adolf Lรผderitz were now under the protection of the German Empire. Treaties of friendship and protection with the natives residing in the interior followed, making this process of colonization fully legal and non-violent. โ€ž๐—ง๐˜„๐—ผ ๐˜๐—ฟ๐—ถ๐—ฏ๐—ฎ๐—น ๐—ด๐—ฟ๐—ผ๐˜‚๐—ฝ๐˜€, ๐˜๐—ต๐—ฒ ๐—›๐—ฒ๐—ฟ๐—ฒ๐—ฟ๐—ผ ๐—ฎ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐—ก๐—ฎ๐—บ๐—ฎ [...] ๐—ต๐—ฎ๐—ฑ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฐ๐—ฒ๐—ป๐˜๐˜‚๐—ฟ๐—ถ๐—ฒ๐˜€.โ€ โž” This may be true for the Herero, less so for the Orlam-Nama groups, some of whom had migrated into the area just one generation before the Germans arrived. Ultimately, none of these groups were truly โ€žindigenousโ€ to the region. They had all come from elsewhere, subduing or displacing the real natives, the Damara and the San. โ€ž๐—ง๐—ต๐—ฒ ๐—ด๐—ฟ๐—ผ๐˜‚๐—ฝ๐˜€ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐˜‚๐—ฎ๐—น๐—น๐˜† ๐—ฟ๐—ถ๐˜€๐—ฒ ๐˜‚๐—ฝ [...] ๐—ฎ๐—ณ๐˜๐—ฒ๐—ฟ ๐—ฏ๐—ฒ๐—ถ๐—ป๐—ด ๐—ฝ๐˜‚๐˜€๐—ต๐—ฒ๐—ฑ ๐—ผ๐—ณ๐—ณ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ๐—ถ๐—ฟ ๐—น๐—ฎ๐—ป๐—ฑ๐˜€.โ€ โž” While the natives did lose a lot of land in the 20 years that followed, this happened neither involuntarily nor forcefully. Tribal chiefs, Samuel Maharero in particular, readily sold off their land to satisfy their worldly desires. โ€ž๐—ง๐—ต๐—ฒ๐˜† ๐—ธ๐—ถ๐—น๐—น๐—ฒ๐—ฑ ๐˜‚๐—ฝ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ผ๐—ณ ๐Ÿญ๐Ÿฒ๐Ÿฌ ๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป ๐˜€๐—ผ๐—น๐—ฑ๐—ถ๐—ฒ๐—ฟ๐˜€.โ€ โž” Soldiers made up only a tiny fraction of the victims. In fact, the Herero had waited for an opportunity to strike unsuspecting and undefended German farmers and merchants, sometimes killing them in their sleep. โ€ž๐—ง๐—ต๐—ฒ ๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป ๐—บ๐—ถ๐—น๐—ถ๐˜๐—ฎ๐—ฟ๐˜† ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐—ฑ๐—ฒ๐—ฑ ๐˜„๐—ถ๐˜๐—ต ๐˜€๐—ผ๐—บ๐—ฒ๐˜๐—ต๐—ถ๐—ป๐—ด ๐—ฐ๐—ฎ๐—น๐—น๐—ฒ๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฒ๐˜…๐—ฒ๐—ฐ๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ฟ๐—ฑ๐—ฒ๐—ฟ.โ€ โž” This order was issued late into the conflict when much of the military engagement was already over and it was quickly rescinded by the General Staff in Berlin after just a couple of weeks. It played a minor role in the overall picture. Also, it is not to be understood literally, as the German General specifically instructed his troops not to shoot at women and children. โ€ž๐—ข๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—น๐—น, ๐˜‚๐—ฝ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ผ๐—ณ ๐Ÿญ๐Ÿฌ๐Ÿฌ,๐Ÿฌ๐Ÿฌ๐Ÿฌ ๐—›๐—ฒ๐—ฟ๐—ฒ๐—ฟ๐—ผ ๐—ฎ๐—ป๐—ฑ ๐—ก๐—ฎ๐—บ๐—ฎ ๐˜„๐—ฒ๐—ฟ๐—ฒ ๐—ธ๐—ถ๐—น๐—น๐—ฒ๐—ฑ...โ€ โž” This figure is more than unlikely considering that even the highest estimates place their combined pre-war population at 120,000. Some estimates are as low as 40,000. No census data exists so the true number may never be known. โ€ž๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป๐˜† ๐˜‚๐˜€๐—ฒ๐—ฑ ๐˜„๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ฒ๐˜† ๐—น๐—ฒ๐—ฎ๐—ฟ๐—ป๐—ฒ๐—ฑ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐—ฐ๐—ผ๐—ป๐—ฐ๐—ฒ๐—ป๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฐ๐—ฎ๐—บ๐—ฝ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐—ต๐˜‚๐—บ๐—ฎ๐—ป ๐—ฏ๐—ผ๐—ฑ๐˜† ๐˜๐—ผ ๐—ฝ๐—ฟ๐—ฒ๐—ฝ๐—ฎ๐—ฟ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—›๐—ผ๐—น๐—ผ๐—ฐ๐—ฎ๐˜‚๐˜€๐˜.โ€ โž” There is no evidence of this whatsoever. The colonial experience with concentration camps had been largely forgotten when Nazism took over.

Leutweins Geist

17,469 ๆฌก่ง‚็œ‹ โ€ข 2 ไธชๆœˆๅ‰

๐ŸŒ๐—”๐—ณ๐—ฟ๐—ถ๐—ฐ๐—ฎ ๐—œ๐˜€ ๐—ก๐—ผ๐˜ ๐—ช๐—ฎ๐—ถ๐˜๐—ถ๐—ป๐—ด โ€” ๐—œ๐˜โ€™๐˜€ ๐—ฆ๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ! Speaking at the Georgia State University Andrew Young School in the United States, during the MandelaWshFellowship, I carried with me the weight of responsibility and generational urgency for Africaโ€™s future โ€” ๐—ฎ ๐—ฟ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐—ฒ๐—ป๐˜ ๐˜๐—ต๐—ฎ๐˜ ๐—ถ๐˜€ ๐—ป๐—ผ๐˜ ๐˜„๐—ฎ๐—ถ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฏ๐—ฒ ๐—ถ๐—ป๐˜ƒ๐—ถ๐˜๐—ฒ๐—ฑ ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—ณ๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ฏ๐˜‚๐˜ ๐—ถ๐˜€ ๐—ฎ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐—น๐˜† ๐˜€๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐—ถ๐˜. โ—ผ๏ธ๐—ง๐—ผ ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ผ๐—ฟ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ถ๐—ป๐˜ƒ๐—ฒ๐˜€๐˜๐—ผ๐—ฟ๐˜€: The real ROI lies in co-creation. Africa is not just the next frontier โ€” ๐—ถ๐˜ ๐—ถ๐˜€ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ถ๐—ป๐—ฑ๐—ถ๐˜€๐—ฝ๐—ฒ๐—ป๐˜€๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฐ๐—ผ-๐—ฎ๐—ฟ๐—ฐ๐—ต๐—ถ๐˜๐—ฒ๐—ฐ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐Ÿฎ๐Ÿญ๐˜€๐˜ ๐—ฐ๐—ฒ๐—ป๐˜๐˜‚๐—ฟ๐˜†. From market stalls transforming into data hubs to farms evolving into predictive engines, young African pioneers are not only reimagining AIโ€™s potential โ€” they are engineering blueprints the world will follow. Partner with us. Invest in our talent pipelines. Scale our homegrown breakthroughs. ๐—ง๐—ต๐—ฎ๐˜ ๐—ถ๐˜€ ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฐ ๐—ณ๐—ผ๐—ฟ๐—ฒ๐˜€๐—ถ๐—ด๐—ต๐˜. โ—ผ๏ธ๐—ง๐—ผ ๐—”๐—ณ๐—ฟ๐—ถ๐—ฐ๐—ฎโ€™๐˜€ ๐—ฏ๐˜‚๐—ถ๐—น๐—ฑ๐—ฒ๐—ฟ๐˜€: Your canvas is the world. Code with purpose. Build with vision. Lead with audacity. Scale your vision globally. The world isnโ€™t waiting ๐—ณ๐—ผ๐—ฟ ๐˜†๐—ผ๐˜‚ โ€”itโ€™s waiting ๐—ผ๐—ป ๐˜†๐—ผ๐˜‚. Donโ€™t catch upโ€”leap ahead. Define whatโ€™s next. This is the future we are building at Otic Group. Our ๐—ฒ๐˜๐—ต๐—ผ๐˜€ is simple: ๐—ง๐—ต๐—ฒ ๐—บ๐—ผ๐˜€๐˜ ๐—ถ๐—ป๐˜๐—ฒ๐—น๐—น๐—ถ๐—ด๐—ฒ๐—ป๐˜, ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ณ๐˜‚๐—น ๐—ถ๐—ป๐˜๐—ฒ๐—น๐—น๐—ถ๐—ด๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ถ๐˜€ ๐—ฎ๐—น๐—ฟ๐—ฒ๐—ฎ๐—ฑ๐˜† ๐—ถ๐—ป ๐˜‚๐˜€. Our work isn't about importing solutions; it's about unlocking that innate brilliance. Do that, and you don't just change a marketโ€”you change the century!

Nesta Paul Katende

167,548 ๆฌก่ง‚็œ‹ โ€ข 1 ๅนดๅ‰

ุงูŽู„ุณูŽู„ุงู…ู ุนูŽู„ูŽูŠู’ูƒูู… ูˆูŽุฑูŽุญู’ู…ูŽุฉู ุงูŽู„ู„ู‡ู ูˆูŽุจูŽุฑูŽูƒุงุชูู‡ู ๐—œ๐˜ ๐—ฐ๐—ผ๐˜€๐˜๐˜€ โ‚ฆ๐Ÿฌ.๐Ÿฌ๐Ÿฌ ๐˜๐—ผ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐˜€๐˜ ๐˜๐—ต๐—ถ๐˜€ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐— ๐˜‚๐˜€๐—น๐—ถ๐—บ ๐—จ๐—บ๐—บ๐—ฎ๐—ต ๐—œ ๐—ฏ๐—ฒ๐˜€๐—ฒ๐—ฒ๐—ฐ๐—ต ๐˜†๐—ผ๐˜‚ ๐—ฎ๐—น๐—น ๐˜๐—ผ ๐—ฝ๐—น๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—ต๐—ฒ๐—น๐—ฝ ๐—พ๐˜‚๐—ผ๐˜๐—ฒ ๐˜๐—ต๐—ถ๐˜€ ๐—ฝ๐—ผ๐˜€๐˜ ๐˜„๐—ถ๐˜๐—ต "๐—ง๐—ผ๐—ด๐—ฒ๐˜๐—ต๐—ฒ๐—ฟ, ๐—น๐—ฒ๐˜ ๐˜‚๐˜€ ๐—ฒ๐—ป๐˜€๐˜‚๐—ฟ๐—ฒ ๐˜€๐˜๐—ฟ๐˜‚๐—ด๐—ด๐—น๐—ถ๐—ป๐—ด ๐—ณ๐—ฎ๐—บ๐—ถ๐—น๐—ถ๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ถ๐—ป๐—ฑ๐—ถ๐˜ƒ๐—ถ๐—ฑ๐˜‚๐—ฎ๐—น๐˜€ ๐—ถ๐—ป ๐—ฑ๐—ถ๐—ฟ๐—ฒ ๐—ป๐—ฒ๐—ฒ๐—ฑ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐˜€๐—ผ๐—บ๐—ฒ๐˜๐—ต๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฒ๐—ฎ๐˜ ๐—ฑ๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—›๐—ผ๐—น๐˜† ๐— ๐—ผ๐—ป๐˜๐—ต ๐—ผ๐—ณ ๐—ฅ๐—ฎ๐—บ๐—ฎ๐—ฑ๐—ฎ๐—ป. ๐—ž๐—ถ๐—ป๐—ฑ๐—น๐˜† ๐——๐—ผ๐—ป๐—ฎ๐˜๐—ฒ" โ‚ฆ๐—ฎ๐—ถ๐—ฟ๐—ฎ ๐—”๐—ฐ๐—ฐ๐—ผ๐˜‚๐—ป๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐˜€: 2035844969 First Bank Feed the Vulnerable Families in [Nigeria} Foundation GofundMe: Paystack: The Prophet ๏ทบ said: โ€œCharity does not decrease wealth, no one forgives another but that Allah [swt] increases his honor, and no one humbles himself for the sake of Allah [swt] but that Allah raises his status.โ€ - [Source: แนขaแธฅฤซแธฅ Muslim 2588] Truly, charity does not decrease your wealth. The more you give, the more you will get back. Charity enhances your wealth and makes it attract barakah, sustenance and Allah [swt's] pleasure in your life. It may be difficult to even think about giving some of your wealth in the cause of Allah [swt], because you lack sufficient possessions to provide your families basic needs. But remember, charity is not just about giving from your wealth, but it includes, giving your time, your words, your actions, your advice, your skills, in the cause of Allah [swt]. Give, even if it's but a sincere intention, and take that step, for you will find sustenance before you. "...And whatever you spend of good [i.e., wealth, property, resources, time, effort etc.] - it will be fully repaid to you, and you will not be wronged." [2:272] Allahumo Baligna Ramadan

๐‘ฐ๐’…๐’“๐’Š๐’” ๐‘จ. ๐‘ถ๐’๐’Š PhD

100,073 ๆฌก่ง‚็œ‹ โ€ข 1 ๅนดๅ‰

๐Ÿ‘๐Ÿ”๐Ÿ“ ๐ƒ๐€๐˜๐’ ๐Ž๐… ๐‡๐„๐€๐‘๐“: ๐Ž๐”๐‘ ๐‰๐Ž๐”๐‘๐๐„๐˜ ๐€๐’ ๐Ž๐๐„ ๐™๐™ค๐™™๐™–๐™ฎ ๐™ข๐™–๐™ง๐™ ๐™จ ๐Ÿฏ๐Ÿฒ๐Ÿฑ ๐™™๐™–๐™ฎ๐™จ ๐™ค๐™› ๐™ช๐™จ, ๐˜พ๐™๐™š๐™›๐™›๐™ž๐™š๐™จ. It has been one whole year since DustBia Official was createdโ€” a journey that began as a simple group supporting ๐——๐˜‚๐˜€๐˜๐—ถ๐—ป ๐—ฌ๐˜‚ ๐—ฎ๐—ป๐—ฑ ๐—•๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฎ ๐——๐—ฒ ๐—ฉ๐—ฒ๐—ฟ๐—ฎ, but grew into something so much deeper. Here we are, 365 days later, still standing and still loving them with the same heart we had at the very beginning. A year ago, we built more than just a fandom; ๐˜„๐—ฒ ๐—ฏ๐˜‚๐—ถ๐—น๐˜ ๐—ผ๐˜‚๐—ฟ ๐˜€๐—ฒ๐—ฐ๐—ผ๐—ป๐—ฑ ๐—ต๐—ผ๐—บ๐—ฒ. Throughout this year, we have experienced everything together: the happiness, the kilig, the late-night fangirling, the laughter, the misunderstandings, and the challenges that tested us as a community. It truly has been a rollercoaster ride. There were highs that made us feel unstoppable and lows that made us question everything. But through it all, we stayed. ๐™’๐™š ๐™˜๐™๐™ค๐™จ๐™š ๐™ฉ๐™ค ๐™จ๐™ฉ๐™–๐™ฎ. ๐—ง๐—ผ ๐—ผ๐˜‚๐—ฟ ๐—ฑ๐—ฒ๐—ฎ๐—ฟ๐—ฒ๐˜€๐˜ ๐—–๐—ต๐—ฒ๐—ณ๐—ณ๐—ถ๐—ฒ๐˜€: Thank you for sticking with us through every up and down. Thank you for supporting Dustin, Bianca, DustBia, and one another. We have sacrificed much and endured much, yet we continue to give the same love over and over again. There were times when we didnโ€™t see eye to eyeโ€” different opinions, perspectives, and ways of expressing supportโ€” but at the end of the day, we all stand for the same reason. We fight for the same people. We love the same community. Words cannot fully express how much we appreciate each of you. We hope that, in our own small way, this community has become a safe space for youโ€” ๐—ฎ ๐—ฝ๐—น๐—ฎ๐—ฐ๐—ฒ ๐˜๐—ผ ๐—ฟ๐—ฒ๐˜€๐˜ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฎ๐—ป ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜„๐—ต๐—ฒ๐—น๐—บ๐—ถ๐—ป๐—ด ๐˜„๐—ผ๐—ฟ๐—น๐—ฑ. Please remember that you are never alone; you have a family here. ๐—ง๐—ผ ๐˜๐—ต๐—ฒ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ถ๐˜€ ๐—ต๐—ผ๐—บ๐—ฒ, ๐——๐˜‚๐˜€๐˜๐—ถ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—•๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฎ: thank you for being the reason we started and the reason we continue. We have come so far because of you. Thank you for your kindness, your patience, and the love you constantly share. This community would not exist without you, and we are endlessly grateful to walk this path by your side. You will always have us. Hereโ€™s to many more years togetherโ€” to more memories, more growth, and more love. May this fandom continue to flourish while staying grounded in kindness and respect. May we always remember our shared goal: ๐˜๐—ผ ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜, ๐˜‚๐—ฝ๐—น๐—ถ๐—ณ๐˜, ๐—ฎ๐—ป๐—ฑ ๐—น๐—ผ๐˜ƒ๐—ฒ ๐—ฏ๐—ผ๐˜๐—ต ๐˜๐—ต๐—ฒ ๐—–๐—ต๐—ฒ๐—ณ๐—ณ๐—ถ๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐——๐˜‚๐˜€๐˜๐—•๐—ถ๐—ฎ, ๐—ถ๐—ป ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜„๐—ฎ๐˜† ๐—ฝ๐—ผ๐˜€๐˜€๐—ถ๐—ฏ๐—น๐—ฒ. One year behind us, an infinite journey ahead, and a love that only grows stronger with time. ๐™ƒ๐™–๐™ฅ๐™ฅ๐™ฎ ๐™–๐™ฃ๐™ฃ๐™ž๐™ซ๐™š๐™ง๐™จ๐™–๐™ง๐™ฎ, ๐˜ฟ๐™ช๐™จ๐™ฉ๐˜ฝ๐™ž๐™– ๐™–๐™ฃ๐™™ ๐˜พ๐™๐™š๐™›๐™›๐™ž๐™š๐™จ. ๐Ÿ’›

TEAM DUSTBIA OFFICIAL

375,227 ๆฌก่ง‚็œ‹ โ€ข 6 ไธชๆœˆๅ‰

๐—ง๐—ต๐—ฒ ๐—ง๐—ถ๐—ด๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐—ฅ๐—ฎ๐—ท๐˜„๐—ฎ๐—ฟ: ๐Ÿญ๐Ÿฏ ๐—ฅ๐—ฒ๐—ท๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€, ๐—” ๐——๐—ฟ๐—ฒ๐—ฎ๐—บ ๐—›๐—ผ๐˜‚๐˜€๐—ฒ, ๐—ฎ๐—ป๐—ฑ ๐—ง๐—ต๐—ฒ ๐—Ÿ๐—ผ๐—ป๐—ด๐—ฒ๐˜€๐˜ ๐—ก๐—ถ๐—ด๐—ต๐˜ The Story That Broke Me: Why Col. Ashutosh Sharma is Different Iโ€™ve written about soldiers who stared death in the face and returned. Iโ€™ve written about those who made the supreme sacrifice. Usually, I can keep my composure. I focus on the facts, the ops, the bravery. But I have to admit:๐—ง๐—ต๐—ฒ ๐˜€๐˜๐—ผ๐—ฟ๐˜† ๐—ผ๐—ณ ๐—–๐—ผ๐—น. ๐—”๐˜€๐—ต๐˜‚๐˜๐—ผ๐˜€๐—ต ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐—ฏ๐—ฟ๐—ผ๐˜‚๐—ด๐—ต๐˜ ๐—บ๐—ฒ ๐˜๐—ผ ๐˜๐—ฒ๐—ฎ๐—ฟ๐˜€. This isn't just a story about a soldier; it is a tragedy of a man who loved so deeply that it hurts to read. ๐—ง๐—ต๐—ฒ "๐Ÿญ๐Ÿฏ๐˜๐—ต" ๐—ง๐—ฟ๐˜† Most of us give up after a bad day. Ashutosh Sharma gave 6 years of his life just to enter the Army. He faced rejection 13 times. Imagine the resilience it takes to cry in your brother's arms after a failure, only to wake up the next morning and say, "๐—ข๐—ป๐—ฒ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜๐—ถ๐—บ๐—ฒ." ๐—ง๐—ต๐—ฒ ๐—œ๐—ฟ๐—ผ๐—ป๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐——๐—ฟ๐—ฒ๐—ฎ๐—บ ๐—›๐—ผ๐˜‚๐˜€๐—ฒ This is the part that broke me. While he was leading the 21 Rashtriya Rifles in Kashmir, his dream house in Jaipur was finally finished. He had promised his wife, Pallavi:"๐—œโ€™๐—น๐—น ๐—ฏ๐—ฒ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ ๐˜€๐—ผ๐—ผ๐—ป ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—š๐—ฟ๐—ถ๐—ต๐—ฎ ๐—ฃ๐—ฟ๐—ฎ๐˜ƒ๐—ฒ๐˜€๐—ต." The invitations were ready. The life he fought so hard to build was waiting for him. ๐—ง๐—ต๐—ฒ ๐—–๐—ต๐—ผ๐—ถ๐—ฐ๐—ฒ ๐—ฎ๐˜ ๐—›๐—ฎ๐—ป๐—ฑ๐˜„๐—ฎ๐—ฟ๐—ฎ May 2020. Pitch dark. Pouring rain. He could have ordered an airstrike. He was the CO; he could have commanded from the back. But he knew civilians were trapped. So, the man who waited 13 attempts to join the Army didn't hesitate for 1 second to risk it all. He went into Close Quarter Battle to save strangers. ๐—ง๐—ต๐—ฒ ๐—ฆ๐—ถ๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ The civilians came out alive. The terrorists were killed. But the radio went silent. The "Tiger" never responded. He returned to Jaipur not for the housewarming he promised, but draped in the Tricolour. ๐—ง๐—ต๐—ฒ ๐—ฆ๐˜๐—ฟ๐—ฒ๐—ป๐—ด๐˜๐—ต ๐—•๐—ฒ๐—ต๐—ถ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐—ง๐—ฒ๐—ฎ๐—ฟ๐˜€ When his wife, Pallavi, received his flag, she refused to let relatives refold it. "No. Don't open it. It has his smell. Leave it like that." Iโ€™ve written many tributes. But this one... this one hits different. He fought to get in. He fought to save others. And he left us with a debt we can never repay. ๐—ง๐—ต๐—ฒ ๐—™๐—ถ๐—ป๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—ฃ๐—น๐—ฎ๐—ฐ๐—ฒ And this is the detail that will stay with you forever. In Hindu tradition, ashes are immersed in the holy Ganges. But his wife, Pallavi, knew her husbandโ€™s true religion was the Olive Green. She didn't take his ashes to a river. She scattered them at the War Memorial in Jaipur. She placed him in the soil of the brave, so he could remain with his brothers forever. ๐—ฃ๐—น๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—ฅ๐—ง. ๐—ก๐—ผ๐˜ ๐—ท๐˜‚๐˜€๐˜ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—ผ๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฒ๐—ฟ, ๐—ฏ๐˜‚๐˜ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—บ๐—ฎ๐—ป ๐˜„๐—ต๐—ผ ๐—ฟ๐—ฒ๐—ณ๐˜‚๐˜€๐—ฒ๐—ฑ ๐˜๐—ผ ๐—พ๐˜‚๐—ถ๐˜. ๐Ÿ‡ฎ๐Ÿ‡ณ Col AJ๐Ÿ‡ฎ๐Ÿ‡ณ Colonel Mayank Chaubey Major Sammer Pal Toorr (Infantry Combat Veteran) ๐Ÿ‡ฎ๐Ÿ‡ณPiush Sharma Aadi Achint ๐Ÿ‡ฎ๐Ÿ‡ณ TheGlobalDecoder #Handwara #IndianArmy #RealHeroes #Bravehearts #TheTiger #JaiHind

The Sacred Scroll

11,369 ๆฌก่ง‚็œ‹ โ€ข 8 ไธชๆœˆๅ‰

๐ŸŽฌWHAT IS THIS SCARYNESS??? 1. โ˜‘๏ธ A person who claimed to be a lawyer in Beijing, ๐˜„๐—ต๐—ผ ๐˜‚๐˜€๐—ฒ๐—ฑ ๐˜๐—ผ ๐—น๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฎ๐—ฟ๐—ฒ๐—ฎ, posted a video sharing his observations. This person stated that they had once lived in Building No. 15, while Yu Menglong passed away in Building No. 18. According to her, the window design there includes a tall frame and sturdy protective grilles. If someone had suddenly jumped out, there would certainly have been signs of damage, yet none were found at the scene. She also emphasized that: - The windows in the apartment open inward rather than outward, making it very difficult for someone to accidentally fall out from a loss of balance. - The height of the window makes the idea of "being drunk and accidentally falling" nearly impossible. - Even under the hypothesis of an intentional suicide, "๐—ผ๐—ป๐—ฒ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ ๐˜€๐˜๐—ถ๐—น๐—น ๐—ป๐—ฒ๐—ฒ๐—ฑ ๐—ฎ ๐—ฟ๐˜‚๐—ป๐—ป๐—ถ๐—ป๐—ด ๐˜€๐˜๐—ฎ๐—ฟ๐˜ ๐˜๐—ผ ๐—บ๐—ฎ๐—ธ๐—ฒ ๐—ถ๐˜ ๐—ต๐—ฎ๐—ฝ๐—ฝ๐—ฒ๐—ป", which she found even more illogical. After Yu Menglong's death, many people questioned why the neighbors on the night of the incident remained silent none called the police or spoke out to clarify what happened. This only fueled suspicions of an "๐—ถ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ๐—ฎ๐—ฑ๐—ฒ". 2.โœ”๏ธ One of the reasons why Song Yiren became the subject of speculation was that she once lived in the same building as Yu Menglong. This was revealed through photos the actress herself had shared on social media. Some online users even pointed out that the room where Yu Menglong fell had a ceiling lamp identical to the one seen in Song Yiren's photos. A wave of rumors then spread, claiming that Song Yiren had also attended the party with Yu Menglong and then she fled to Japan after the incident. ๐—ฆ๐—ผ๐—ป๐—ด ๐—ฌ๐—ถ๐—ฟ๐—ฒ๐—ป ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฑ ๐—ผ๐—ป ๐˜๐—ต๐—ฒ 3๐—ฟ๐—ฑ ๐—ณ๐—น๐—ผ๐—ผ๐—ฟ ๐—ผ๐—ณ ๐—•๐˜‚๐—ถ๐—น๐—ฑ๐—ถ๐—ป๐—ด 18, ๐˜„๐—ต๐—ถ๐—น๐—ฒ ๐—ฌ๐˜‚ ๐— ๐—ฒ๐—ป๐—ด๐—น๐—ผ๐—ป๐—ด ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฑ ๐—ผ๐—ป ๐˜๐—ต๐—ฒ 5๐˜๐—ต ๐—ณ๐—น๐—ผ๐—ผ๐—ฟ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜€๐—ฎ๐—บ๐—ฒ ๐—ฏ๐˜‚๐—ถ๐—น๐—ฑ๐—ถ๐—ป๐—ด. 3.๐Ÿ“ž A brave female lawyer publicly said in the video that she was willing to represent this case for free. However, this action had to pay a high price: the female lawyer disappeared and was suspected of being banned and silenced. ๐Ÿ‘‰ speak up to help Yu Menglong's family prepare the proceedings. 4.โ™Ÿ๏ธ Silence anyone who voices opinions about the case and claims it's fabricated or challenges the police from celebrities to ordinary people. ๐—จ๐˜€๐—ฒ ๐˜๐—ต๐—ฒ "๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฒ๐˜ ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ป๐˜€๐—ถ๐—ป๐—ด" ๐—น๐—ฎ๐˜„ ๐˜๐—ผ ๐—ฑ๐—ฒ๐—น๐—ฒ๐˜๐—ฒ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐˜‚๐—ป๐˜๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ผ๐˜€๐˜๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—ฟ๐—ฟ๐—ฒ๐˜€๐˜ ๐—ฝ๐—ฒ๐—ผ๐—ฝ๐—น๐—ฒ. 5. โšซ๏ธ A police officer who wanted to question and reinvestigate the case (not from the Chaoyang precinct) was also disciplined and dismissed from his position. 6.๐ŸŒซ๏ธ ๐—˜๐—ฟ๐—ฎ๐˜€๐—ฒ ๐—ฎ๐—น๐—น ๐—ถ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ ๐—ฌ๐˜‚ ๐— ๐—ฒ๐—ป๐—ด๐—น๐—ผ๐—ป๐—ด ๐—ณ๐—ฟ๐—ผ๐—บ ๐˜€๐—ผ๐—ฐ๐—ถ๐—ฎ๐—น ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฎ. For example, his music releases, song links, MVs, and event posts on Weibo none of the links can be accessed anymore, even though they were part of his professional work. His name has also been removed from film and television projects. 7.โž• People from outside who wanted to come to Beijing to speak up and demand justice were also advised not to go. They were warned that if they did, it would be very dangerous - they might never be seen again. โ€ผ๏ธ ๐Ÿ‘‰ Blacklist๐Ÿ–ค #ไบŽๆœฆๆœงๅขœๆจ“ไบ‹ไปถ #YuMenglongFallingEvent #justiceforyumenglong #ไบŽๆœฆ่ƒงๅ ๆฅผ #YuMenglong #ไบŽๆœฆ่ƒง #AlanYu #YuMenglong #JusticeforYuMenglong #YuMenglongไบŽๆœฆ่ƒง #ไบŽๆœฆ่ƒง

๋ฏธ๋‚˜๋ฌธ๐ŸŒ™ ๐Ÿ‡ฐ๐Ÿ‡ท๐Ÿ‡น๐Ÿ‡ผ

155,048 ๆฌก่ง‚็œ‹ โ€ข 1 ๅนดๅ‰

This isnโ€™t โ€œ$300M vanishedโ€ clickbait. In 2022, TELUS said the quiet part out loud, adoption was a problem. By May 2024, Infoway was looking for new ownership. MPs asked for contracts, IP terms, payments and penalties between Infoway & Telus! That's when Camera's go dark!!! I know it's longer than usual, but it's worth it if you really want to know why the Liberals shut down committee yesterday. I pull back the curtains on what they're hiding for anyone who wants to know! ๐—™๐—ผ๐—น๐—น๐—ผ๐˜„ ๐—ฎ๐—ป๐—ฑ ๐˜€๐—ต๐—ฎ๐—ฟ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—ฐ๐—ผ๐—ป๐˜๐—ฒ๐—ป๐˜ ๐—น๐—ถ๐—ธ๐—ฒ ๐˜๐—ต๐—ถ๐˜€. ๐—ง๐—ฟ๐˜†๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฏ๐—ฒ ๐—ฎ ๐˜€๐—ผ๐˜‚๐—ฟ๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ฝ๐—ผ๐—ถ๐—ป๐˜๐˜€/๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ถ๐—ฝ๐˜๐˜€ ๐—ป๐—ผ๐˜ ๐—ท๐˜‚๐˜€๐˜ ๐—ฐ๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—ฟ๐˜†. PrescribeIT is the kind of government failure that hides behind words like digital health, innovation, and modernization. We've seen it before from Liberals with things like Arrivescam. In plain English, it was supposed to help doctors send prescriptions to pharmacies without dragging the country through another decade of fax machines. Then federal money went to Canada Health Infoway, TELUS became the major technical player, and suddenly a simple prescription system turned into a nearly $300 million procurement swamp. โ€œ๐—”๐—ป๐—ฑ ๐˜๐—ต๐—ฎ๐˜โ€™๐˜€ ๐˜„๐—ต๐—ฒ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—ป๐—ถ๐—ฐ๐—ฒ ๐—น๐—ถ๐˜๐˜๐—น๐—ฒ ๐—บ๐—ผ๐—ฑ๐—ฒ๐—ฟ๐—ป๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐˜€๐˜๐—ผ๐—ฟ๐˜† ๐˜€๐˜๐—ฎ๐—ฟ๐˜๐˜€ ๐—ด๐—ฒ๐˜๐˜๐—ถ๐—ป๐—ด ๐˜‚๐—ด๐—น๐˜†.โ€ Michael Green, Infowayโ€™s CEO, sits in the middle of the institutional story. TELUS wasnโ€™t some side contractor either. They were selected in 2017 to help build and operate PrescribeIT by Infoway themselves. Then in 2022, TELUS basically said the quiet part out loud: adoption was a problem because doctors, pharmacies, EMR vendors, and pharmacy systems all had to play along and the foreboding reality was they weren't, and yet money still kept flowing to this obviously failed project. โ€œ๐—ช๐—ต๐—ถ๐—ฐ๐—ต ๐—ถ๐˜€ ๐—ฎ ๐—ฏ๐—ฟ๐—ถ๐—น๐—น๐—ถ๐—ฎ๐—ป๐˜ ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น, ๐—ฎ๐˜€๐˜€๐˜‚๐—บ๐—ถ๐—ป๐—ด ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—บ๐—ผ๐˜ƒ๐—ถ๐—ป๐—ด ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ถ๐—ป ๐—–๐—ฎ๐—ป๐—ฎ๐—ฑ๐—ถ๐—ฎ๐—ป ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐˜€๐˜‚๐—ฑ๐—ฑ๐—ฒ๐—ป๐—น๐˜† ๐—ฏ๐—ฒ๐—ต๐—ฎ๐˜ƒ๐—ฒ๐˜€ ๐—น๐—ถ๐—ธ๐—ฒ ๐—ผ๐—ป๐—ฒ ๐—บ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ป๐—ฒ.โ€ Then comes the money. TELUS reportedly received about $98 million, while PrescribeIT failed to reach the adoption needed to survive and they knew about this since 2022. So the real question isnโ€™t just what Ottawa spent. Itโ€™s what taxpayers actually bought. What did Canada own? What did Infoway own? What did TELUS own? Turns out Telus owns it all and we just gave them free money and they keep all the tech. โ€œ๐—”๐—ป๐—ฑ ๐˜๐—ต๐—ฎ๐˜ ๐—ฏ๐—ฟ๐—ถ๐—ป๐—ด๐˜€ ๐˜‚๐˜€ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฎ๐—ฝ๐—ฒ๐—ฟ๐˜„๐—ผ๐—ฟ๐—ธ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜†๐—ผ๐—ป๐—ฒ ๐˜€๐˜‚๐—ฑ๐—ฑ๐—ฒ๐—ป๐—น๐˜† ๐—ด๐—ผ๐˜ ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ป๐—ฒ๐—ฟ๐˜ƒ๐—ผ๐˜‚๐˜€ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜.โ€ Matt Strauss asked for the actual file: the 2017 Infoway-TELUS contract, amendments, renewals, IP ownership records, payment records, penalties, and termination details. In other words, the paper trail that would show whether the public got value or got played. โ€œ๐—ง๐—ต๐—ฒ๐—ป ๐—Ÿ๐—ถ๐—ฏ๐—ฒ๐—ฟ๐—ฎ๐—น ๐— ๐—ฃ ๐—ฆ๐—ผ๐—ป๐—ถ๐—ฎ ๐—ฆ๐—ถ๐—ฑ๐—ต๐˜‚ ๐—บ๐—ผ๐˜ƒ๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ฑ๐—ฒ๐—น๐—ฒ๐˜๐—ฒ ๐˜๐—ต๐—ฎ๐˜ ๐—ฒ๐˜…๐—ฎ๐—ฐ๐˜ ๐˜€๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป.โ€ Not the fluff. Not the slogans. The contract guts. So when the meeting reportedly went dark, the fair question is obvious: why does a failed e-prescribing project need this much discretion around who got paid, who owned what, and what Canada was left holding when it all fell apart? Vesper

Vesper

22,506 ๆฌก่ง‚็œ‹ โ€ข 5 ไธชๆœˆๅ‰

GM GM GM ! (เน‘โœชแ†บโœชเน‘)/โค๏ธ ๐Ÿ”ฅ๐—˜๐—ซ๐—ฃ๐—ข๐—ฆ๐—œ๐—ก๐—š ๐—ง๐—›๐—˜ ๐—ง๐—ฅ๐—จ๐—ง๐—›๐Ÿ”ฅ โœจ๐…๐ˆ๐‘๐’๐“ โ€” A BIG shoutout to ๐—•๐—•๐—ก๐—ข$ & ๐—œ๐—ฅ๐—ข๐—ก๐— ๐—ข๐—จ๐—ฆ๐—˜ for the dopest song of ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“! ๐ŸŽฌ๐—š๐—ผ ๐˜€๐˜‚๐—ฏ๐˜€๐—ฐ๐—ฟ๐—ถ๐—ฏ๐—ฒ & ๐—ณ๐—ผ๐—น๐—น๐—ผ๐˜„ them, see the full-quality video โ€” links at the end of this article. โ›ฉ๏ธ๐—œ๐˜'๐˜€ ๐˜๐—ต๐—ฒ ๐—ณ๐—ถ๐—ป๐—ฎ๐—น ๐—ฝ๐—ผ๐˜€๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜„๐—ฒ๐—ฒ๐—ธ ๐˜€๐—ผ ๐˜†๐—ผ๐˜‚ ๐—ธ๐—ป๐—ผ๐˜„ ๐—ถ๐˜ ๐—ฐ๐—ผ๐—บ๐—ฒ๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐—ธ๐—ป๐—ผ๐˜„๐—น๐—ฒ๐—ฑ๐—ด๐—ฒ ๐˜€๐—ผ ๐—น๐—ฒ๐˜'๐˜€ ๐—ฑ๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐Ÿ”ป โ™ฆ๏ธAs I mentioned before, I really donโ€™t understand how people keep falling for these infoFi scams and other post-grinding projects. ๐Ÿ”ธIโ€™m talking about Loudio, P33lio, Yapyo, Fukyo โ€” you know them all. You all get RUGGED every time but still keep doing it. ๐Ÿ”ธDo you really think Spermify ( you all know who Iโ€™m referring to ) or other web3 brands give a shit if you lose money, time, and effort? Of course not โ€” but you should. ๐Ÿ”ธAnd hereโ€™s why๐Ÿ”ป ~ ๐—ฆ๐—˜๐—–๐—ฅ๐—˜๐—ง: The top 10 โ€œinfluencersโ€ you see as web3 gods are not grinding like you โ€” they are paid per post. I know because I was offered the same. Also, they are not real influencers โ€” real influencers charge thousands of $$$ per post and do not shill anything. ~ They donโ€™t give a shit because they get paid upfront. But you shill daily for nothing โ€” and the worst part is, you shill to your own community and followers. Do you even realize how many people lose money because you donโ€™t think about what youโ€™re doing? ~ What if you had to pay back every person in your community who invested in what you shilled and then lost everything? ~ ๐—š๐—ฅ๐—ข๐—ช ๐—ง๐—›๐—˜ ๐—™๐—ž ๐—จ๐—ฃ ๐—”๐—ก๐—— ๐—ฆ๐—ง๐—”๐—ฅ๐—ง ๐—•๐—˜๐—œ๐—ก๐—š ๐—ฅ๐—˜๐—ฆ๐—ฃ๐—ข๐—ก๐—ฆ๐—œ๐—•๐—Ÿ๐—˜ ๐—™๐—ข๐—ฅ ๐—ช๐—›๐—”๐—ง ๐—ฌ๐—ข๐—จ ๐—ฃ๐—ข๐—ฆ๐—ง. Iโ€™m referring to people who have communities that actually follow their calls and post โ€” not just simple creators shilling anything. โ™ฆ๏ธIf you ever see me launch another NFT project or a coin, know that I guarantee your money back if youโ€™re not satisfied. No shady shit โ€” Senpai never toys with peopleโ€™s funds! โ™ฆ๏ธYouโ€™ll rarely see me post anything, because I donโ€™t post bullshit. I donโ€™t want to harm anyoneโ€™s wallet, so I prefer to REFUSE the $$$ โ€” no matter the amount! โ™ฆ๏ธ Youโ€™ll see people saying they never engage in drama โ€” yet all their posts are nothing but attention-seeking drama. Donโ€™t believe me? Just look around. โ™ฆ๏ธ Youโ€™ll see โ€œsmartโ€ mofos claiming other people arenโ€™t organic. Mferโ€ฆ NOTHING in web3 is organic. Not a single post. All the comments are in exchange for something โ€” whether from influencers or projects. They just talk shit coz their accounts & persona are nothing and they are lazy to work for it! โ™ฆ๏ธThereโ€™s a lot of FUD regarding girls in web3. While some girls are real gamers or content creators, keep in mind that literally 95% are managed by dudes โ€” even if the photos or videos are real. Also, notice how many of the girls you guys goon over in web3 today just removed all their booty photos after they got followers & attention, or deleted all the photos with themselves. If anyoneโ€™s curious, DM me โ€” there are peeps that have all their sexy pics, even if they deleted them. ๐Ÿ”ธNow they claim to be gamer influencers, but we also have proof that theyโ€™re completely managed by dudes ( literally the guys confessing they do everything for them ). Iโ€™m not saying all web3 females are fake, but just donโ€™t get fooled bros, ur talking to guys not girls. ๐Ÿ’ฎ๐—œ๐—ณ ๐˜†๐—ผ๐˜‚โ€™๐—ฟ๐—ฒ ๐—ฎ ๐˜„๐—ผ๐—บ๐—ฎ๐—ป ๐˜„๐—ต๐—ผโ€™๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—ฟ๐—ฒ๐—ฎ๐—น ๐—ฎ๐—ป๐—ฑ ๐˜„๐—ผ๐—ฟ๐—ธ๐˜€ ๐—ต๐—ฎ๐—ฟ๐—ฑ ๐—ถ๐—ป ๐—ช๐—ฒ๐—ฏ3, ๐—ฎ๐—น๐—น ๐˜๐—ต๐—ฒ ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜ ๐—ฎ๐—ป๐—ฑ ๐—น๐—ผ๐˜ƒ๐—ฒ ๐˜๐—ผ ๐˜†๐—ผ๐˜‚. ๐—ž๐—ฒ๐—ฒ๐—ฝ ๐—ฝ๐˜‚๐˜€๐—ต๐—ถ๐—ป๐—ด โ€” ๐˜„๐—ผ๐—บ๐—ฒ๐—ป ๐—ฐ๐—ฎ๐—ป ๐—ฑ๐—ผ ๐—ฎ๐—ป๐˜†๐˜๐—ต๐—ถ๐—ป๐—ด ๐—ฎ ๐—บ๐—ฎ๐—ป ๐—ฐ๐—ฎ๐—ป, ๐—ฎ๐—ป๐—ฑ ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐—ฏ๐—ฒ๐˜๐˜๐—ฒ๐—ฟ๐Ÿงก โ™ฆ๏ธWhy do I make these posts? Because someone has to, so people donโ€™t get scammed, rugged, and so on! โ™ฆ๏ธIf youโ€™re a bit confused, go read my other posts๐Ÿ”ป ~ ~ ~ ~ ~ โ™ฆ๏ธIf you see Senpai post something, you know itโ€™s legit. โ™ฆ๏ธIf you disagree with what I said, then Iโ€™m sorry โ€” the truth always hurts. I probably touched your little attention-whore soft spot, and thatโ€™s why youโ€™ll never have the balls to post the truth like some of us. Youโ€™re too afraid to harm your perfect ๐—™๐—”๐—ž๐—˜ ๐—ฅ๐—˜๐—ฃ๐—จ๐—ง๐—”๐—ง๐—œ๐—ข๐—ก! โ™ฆ๏ธ BROKIES DO IT FOR THE B!TCHES! โ™ฆ๏ธ LEGENDS HAVE B!TCHES TO DO IT FOR THEM! โ™ฆ๏ธ I CAN RETIRE JUST WITH MY WRISTโœจโŒš๏ธโœจ โ™ฆ๏ธ SENPAI WILL NOT SHILL YOUR RUGS MOFOS! ๐Ÿ”ฅ๐—๐˜‚๐˜€๐˜ ๐—ฎ ๐—น๐—ถ๐˜๐˜๐—น๐—ฒ ๐—ป๐—ผ๐˜๐—ถ๐—ฐ๐—ฒ & ๐—ฎ๐—น๐—ฝ๐—ต๐—ฎ: ๐˜„๐—ฒ๐—ฏ2 ๐—ถ๐—ป๐—ณ๐—น๐˜‚๐—ฒ๐—ป๐—ฐ๐—ฒ๐—ฟ๐˜€ ๐—ด๐—ฒ๐˜ $10๐—ธ ๐—ฒ๐—ฎ๐˜€๐˜† ๐—ฝ๐—ฒ๐—ฟ ๐• ๐—ฝ๐—ผ๐˜€๐˜. ๐—ช๐—ผ๐—ผ๐—ฝ ๐—ช๐—ผ๐—ผ๐—ฝ๐Ÿ”ฅ ๐ŸŒธ๐‘ฐ ๐’‰๐’๐’‘๐’† ๐’š๐’๐’– ๐’†๐’๐’‹๐’๐’š๐’†๐’… ๐’•๐’‰๐’Š๐’” ๐’๐’Š๐’•๐’•๐’๐’† ๐’‘๐’๐’”๐’• & ๐’š๐’๐’– ๐’˜๐’Š๐’๐’ ๐’‰๐’‚๐’—๐’† ๐’‚ ๐’๐’๐’—๐’†๐’๐’š ๐’˜๐’†๐’†๐’Œ๐’†๐’๐’… ๐’‚๐’‰๐’†๐’‚๐’…๐Ÿ’œ ๐ŸŽฌ๐—ฆ๐—จ๐—•๐—ฆ๐—–๐—ฅ๐—œ๐—•๐—˜ ๐˜๐—ผ ๐—•๐—•๐—ก๐—ข$: ๐ŸŽฌ๐—ฆ๐—จ๐—•๐—ฆ๐—–๐—ฅ๐—œ๐—•๐—˜ ๐˜๐—ผ ๐—œ๐—ฅ๐—ข๐—ก๐— ๐—ข๐—จ๐—ฆ๐—˜: โญ๏ธ๐˜๐Ž๐” ๐‚๐€๐ ๐…๐ˆ๐๐ƒ ๐€๐‹๐‹ ๐“๐‡๐„๐ˆ๐‘ ๐’๐Ž๐‚๐ˆ๐€๐‹๐’ ๐“๐‡๐„๐‘๐„โญ๏ธ

๐ŸŒธ๐’๐„๐๐๐€๐ˆ ๅ…ˆ่ผฉ๐Ÿœ

304,968 ๆฌก่ง‚็œ‹ โ€ข 1 ๅนดๅ‰

$NWBO #DCVaxForBraelyn #GBM Siobhain, Margaretโ€™s Trial deserves support. Your campaign could also put an urgent question to government: ๐—ช๐—ต๐˜† ๐—ฑ๐—ผ๐—ฒ๐˜€ #๐——๐—–๐—ฉ๐—ฎ๐˜…-๐—Ÿ ๐˜€๐˜๐—ถ๐—น๐—น ๐—ฎ๐˜„๐—ฎ๐—ถ๐˜ ๐—ฎ๐—ป ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฎ๐—น ๐—ฑ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป? Northwest Biotherapeutics has completed a phase III programme, published survival findings, documented a favourable safety record across thousands of doses, and developed a platform with a compelling rationale for combination treatment. The company and the people behind that work deserve to be part of this conversation. ๐——๐—ฟ. ๐—”๐—น๐˜๐—ผ๐—ป ๐—•๐—ผ๐˜†๐—ป๐˜๐—ผ๐—ป. ๐——๐—ฟ. ๐— ๐—ฎ๐—ฟ๐—ป๐—ถ๐˜… ๐—•๐—ผ๐˜€๐—ฐ๐—ต. ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ฒ๐˜€๐˜€๐—ผ๐—ฟ ๐—ž๐—ฒ๐˜†๐—ผ๐˜‚๐—บ๐—ฎ๐—ฟ๐˜€ ๐—”๐˜€๐—ต๐—ธ๐—ฎ๐—ป. Boynton co-founded Northwest. Bosch joined in 2000 and spearheaded development of its manufacturing and quality-control processes, alongside clinical protocols and regulatory submissions. Their work helped turn dendritic-cell biology into a personalised product that could be manufactured, transported and administered across an international clinical programme. That translation is an achievement in itself. Every patient supplies different cells and a different tumour. The treatment must still be prepared consistently enough to test and deliver. Here in Britain, Professor Keyoumars Ashkan, neurosurgeon at Kingโ€™s College Hospital, served as the trialโ€™s European Chief Investigator. He is a coauthor of the phase III publication, alongside UCLAโ€™s Dr. Linda Liau, Boynton, Bosch and the international clinical team. ๐—•๐—ฟ๐—ถ๐˜๐—ถ๐˜€๐—ต ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ถ๐—ฎ๐—ป๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐—ต๐—ฒ๐—น๐—ฝ๐—ฒ๐—ฑ ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ฒ ๐˜๐—ต๐—ถ๐˜€ ๐—ฒ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ. The scientific argument begins with a basic requirement: the immune system needs effective instruction about what to attack. Dendritic cells present tumour antigens, provide activating signals and shape the responding T cells. Tumours can interfere with that process. DCVax-L makes preparation of those instructing cells part of treatment. The patientโ€™s own dendritic cells are prepared outside the tumour environment and loaded with material from the patientโ€™s own tumour. Whole-tumour material supplies a broad range of potential targets through the patientโ€™s own presentation machinery. That matters in glioblastoma, where different cancer cells can carry different targets. ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป๐—ฎ๐—น๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ฒ๐—น๐—น ๐—ฑ๐—ผ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐˜๐—ฒ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ป๐—ด. The work discussed by Lisa Butterfield and Pawel Kalinski makes preparation even more consequential. Cells can pass routine checks while retaining signalling or metabolic defects. A mature appearance does not establish effective immune instruction. Starting-cell quality, culture conditions and maturation signals all shape function. IL-12p70 is an important part of type-1 instruction, but no single marker establishes the entire cellโ€™s performance. This is why Boschโ€™s manufacturing work matters biologically. Preparing the cell creates an opportunity to assess and improve the instruction before treatment reaches the patient. ๐—ง๐—ต๐—ฒ๐—ป ๐˜๐—ต๐—ฒ ๐˜€๐—ฒ๐—พ๐˜‚๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—บ๐—ฎ๐˜๐˜๐—ฒ๐—ฟ๐˜€. Pembrolizumab releases inhibition on T cells. Dendritic-cell vaccination can help generate the tumour-directed response that checkpoint treatment is intended to support. UCLAโ€™s EANO 2026 report examined its related ATL-DC vaccine with poly-ICLC and pembrolizumab in recurrent glioblastoma. Among the analysed IDH-wildtype patients: ๐—ฉ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ณ๐—ผ๐—น๐—น๐—ผ๐˜„๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ฝ๐—ฒ๐—บ๐—ฏ๐—ฟ๐—ผ๐—น๐—ถ๐˜‡๐˜‚๐—บ๐—ฎ๐—ฏ: ๐Ÿฑ๐Ÿฑ๐Ÿฑ ๐—ฑ๐—ฎ๐˜†๐˜€ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐—ป ๐˜€๐˜‚๐—ฟ๐˜ƒ๐—ถ๐˜ƒ๐—ฎ๐—น. ๐—ฃ๐—ฒ๐—บ๐—ฏ๐—ฟ๐—ผ๐—น๐—ถ๐˜‡๐˜‚๐—บ๐—ฎ๐—ฏ ๐—ฏ๐—ฒ๐—ณ๐—ผ๐—ฟ๐—ฒ ๐˜€๐˜‚๐—ฟ๐—ด๐—ฒ๐—ฟ๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—น๐—ผ๐—ป๐—ด๐˜€๐—ถ๐—ฑ๐—ฒ ๐˜ƒ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป: ๐Ÿฎ๐Ÿณ๐Ÿญ ๐—ฑ๐—ฎ๐˜†๐˜€. The groups contained 16 and 19 patients. This small, amended trial also found greater T-cell infiltration and interferon/granzyme-B signals in the vaccine-first group. Earlier/concurrent treatment was associated with chronic inflammatory responses. Elevated interferon responses before treatment tracked with shorter survival. The distinction matters: timing, location and the state of the immune system can change what an immune signal accomplishes. ๐—˜๐˜€๐˜๐—ฎ๐—ฏ๐—น๐—ถ๐˜€๐—ต ๐˜๐—ต๐—ฒ ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐˜€๐—ฒ. ๐—ง๐—ต๐—ฒ๐—ป ๐—ต๐—ฒ๐—น๐—ฝ ๐—ถ๐˜ ๐˜„๐—ผ๐—ฟ๐—ธ. EANO 2026, abstract MO03.4.A: Trial: The vaccine course allowed only three doses, two weeks apart. Pembrolizumab continued; vaccination ended within weeks. A short course was followed by a survival difference measured months later. Immune memory, recruitment of the patientโ€™s own dendritic cells, reciprocal signalling and recognition of additional tumour targets offer biological routes to a response that outlasts the injected cells. Their contribution requires measurement, but the possibility is central to the strategy. And 555 days is the median. Longer follow-up is needed to reveal the survival tail. ๐——๐—–๐—ฉ๐—ฎ๐˜…-๐—Ÿ ๐—ฎ๐—น๐—ฟ๐—ฒ๐—ฎ๐—ฑ๐˜† ๐—ต๐—ฎ๐˜€ ๐—ฎ ๐—บ๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ๐—ฑ ๐—ณ๐—ถ๐˜ƒ๐—ฒ-๐˜†๐—ฒ๐—ฎ๐—ฟ ๐˜๐—ฎ๐—ถ๐—น. Northwestโ€™s phase III publication reported five-year survival of 13.0% versus 5.7% in newly diagnosed glioblastoma, compared with external controls. At recurrence, median survival was 13.2 months versus 7.8 months. Across 2,151 doses, investigators reported five serious adverse events considered at least possibly treatment-related, with no evidence of autoimmune reactions or cytokine storm. The recurrence finding adds another important insight: those vaccines were manufactured from the original tumour. Forty-six of the 64 crossover patients had no second surgery. The original tumour material remained the basis of treatment after recurrence. DCVax-Lโ€™s phase III schedule also continued beyond initial priming, with repeat doses through month 30. That provides a rationale for studying reinforcement of the response. Comparing cell counts across different products cannot establish comparative potency; what matters is the immune response those cells generate. ๐—ก๐—ผ๐—ฟ๐˜๐—ต๐˜„๐—ฒ๐˜€๐˜ ๐—ต๐—ฎ๐˜€ ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ๐—ฑ ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ฒ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ. In July 2026, Bosch presented updated analyses using individual patient data. Northwest reported that independent statisticians applied propensity-score matching and inverse-probability weighting. The survival advantage persisted across methods and comparator datasets. Matching yielded median advantages of 3.4โ€“6.3 months. More detailed comparisons strengthened the reported signal. Full publication will allow independent scrutiny. The companyโ€™s broader development programme follows the same biological logic: Prepare effective dendritic cells. Present a broad range of tumour targets. Generate and, where appropriate, expand tumour-reactive cells. Help them enter the tumour. Address suppression and study checkpoint timing. Investigate how to reinforce and sustain the response. Northwest has licensed complementary technologies developed by Kalinskiโ€™s teams. DCVax-Direct explores acquiring tumour material inside the body. Its Flaskworks/Eden programme addresses the manufacturing capacity needed to deliver personalised cell treatment more widely. These programmes require their own validation. Their significance is the connected strategy: improving the instructor, supporting the responding cells and building the means to manufacture treatment at scale. ๐—ง๐—ต๐—ฒ ๐—ฝ๐—ฒ๐—ผ๐—ฝ๐—น๐—ฒ ๐˜„๐—ต๐—ผ ๐—ฏ๐˜‚๐—ถ๐—น๐˜ ๐˜๐—ต๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ๐—บ๐—ฒ ๐˜€๐—ต๐—ผ๐˜‚๐—น๐—ฑ ๐—ฏ๐—ฒ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐—ฑ. The UK application was submitted in December 2023. In July 2026, Northwest reported MHRA confirmation that it remained under review and had not been refused. Siobhain, please invite Northwest, Dr. Boynton, Dr. Bosch and Professor Ashkan to explain the evidence and the remaining steps directly to your campaign and parliamentary colleagues. Then ask government and the company for a clear account of what remains unresolved, who must resolve it, and when a decision can be reached. Press for a practical access plan alongside that work. DCVax-Lโ€™s survival findings, safety record and biological rationale make a compelling case for its potential role as a treatment foundation. The people who developed it and the clinicians who tested it can explain that case in detail. ๐—˜๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฟ๐—ฒ๐—บ๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐—ฟ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ป๐—ฒ๐—ฒ๐—ฑ๐˜€ ๐—ฎ๐—ป ๐—ผ๐˜„๐—ป๐—ฒ๐—ฟ, ๐—ฎ ๐—ป๐—ฒ๐˜…๐˜ ๐˜€๐˜๐—ฒ๐—ฝ ๐—ฎ๐—ป๐—ฑ ๐—ฎ ๐˜๐—ถ๐—บ๐—ฒ๐˜๐—ฎ๐—ฏ๐—น๐—ฒ. ๐—™๐—ฎ๐—บ๐—ถ๐—น๐—ถ๐—ฒ๐˜€ ๐—ฎ๐—ฟ๐—ฒ ๐—บ๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฎ๐˜ ๐˜๐—ถ๐—บ๐—ฒ ๐—ถ๐—ป ๐—ฏ๐—ถ๐—ฟ๐˜๐—ต๐—ฑ๐—ฎ๐˜†๐˜€, ๐—ด๐—ฟ๐—ฎ๐—ฑ๐˜‚๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐—บ๐—ผ๐—ฟ๐—ป๐—ถ๐—ป๐—ด ๐˜๐—ผ๐—ด๐—ฒ๐˜๐—ต๐—ฒ๐—ฟ.

Andrew Caravello, DO

61,089 ๆฌก่ง‚็œ‹ โ€ข 2 ๅคฉๅ‰

Our first duty as members of Parliament is to protect Australians. Fifteen women linked to the listed terrorist organisation ISIS have returned to Australia while this government has been in office. Two women facing serious charges, one for alleged terrorism offences and one for alleged ISIS-related slavery offences, are already free on bail in our community. Now it is reported that thirteen men who served ISIS are being held in prison in Baghdad. They include Perth-born doctor Tareq Kamleh, known as โ€˜Dr Jihadโ€™. Kamleh travelled to Syria to join ISIS, appeared in terrorist propaganda videos. In one propaganda video, Kamleh urged Muslims to travel to ISIS-controlled territory or wage jihad elsewhere. He declared that โ€˜jihad itself isnโ€™t only in the lands of Syria or Iraqโ€™ and that fighting for the cause could occur โ€˜anywhereโ€™. Kamleh and other individuals who reportedly served ISIS may soon be released from custody and seek to return to Australia. The Home Affairs Minister says existing law may require him to permit their return. That is not good enough. If the law prevents a minister from protecting Australians, Parliament must change the law. Even more concerning is that the conduct of the Home Affairs Minister suggests he is aiding this return. Handwritten departmental notes from a secret meeting with advocates lobbying for the return of these ISIS-linked individuals recorded remarks attributed to โ€˜TBโ€™, including โ€˜cโ€™ment to find a wayโ€™, โ€˜donโ€™t want govt to rule it outโ€™ and โ€˜success of first cohort will be great help after weโ€™ve got them homeโ€™. A separate record of the same secret meeting reveals that the Minister thanked advocates for keeping their lobbying out of the media. A departmental official was then asked to leave to enable a โ€˜frank discussionโ€™. Before leaving, the official recorded the Minister saying that there โ€˜may be a way to achieve the same outcome without government undertakingsโ€™. On their face, these records show the Minister discussing how the return of ISIS-linked individuals might be achieved without a formal government undertaking, while thanking those involved for keeping the matter out of the media. That is incompatible with his most fundamental duty as Home Affairs Minister: to protect Australians. We do not know what was discussed after the departmental official left the room. We do not know whether any commitments were made, or whether any proposed pathway is being used to return male ISIS fighters. I recently wrote to the Leader of the Opposition, offering to work together to strengthen the Oppositionโ€™s bill. I received a response from him yesterday afternoon at 3:41pm. The Oppositionโ€™s bill from earlier this year is a step in the right direction, but it does not go far enough. Senator Duniam has acknowledged its central limitation: the Oppositionโ€™s bill does not prevent ISIS-linked individuals from entering Australia. That leaves the central problem unresolved. A bill that cannot prevent foreign terrorist fighters from returning does not adequately protect Australians. We have therefore prepared the Protecting Australians from Foreign Terrorist Fighters Bill 2026. The Bill would: ๐Ÿญ. ๐—–๐—ฟ๐—ฒ๐—ฎ๐˜๐—ฒ ๐—ฎ ๐—ณ๐—ผ๐—ฟ๐—ฒ๐—ถ๐—ด๐—ป ๐˜๐—ฒ๐—ฟ๐—ฟ๐—ผ๐—ฟ๐—ถ๐˜€๐˜ ๐—ณ๐—ถ๐—ด๐—ต๐˜๐—ฒ๐—ฟ ๐—ฒ๐˜…๐—ฐ๐—น๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐—ผ๐—ฟ๐—ฑ๐—ฒ๐—ฟ. The Home Affairs Minister could apply to the Federal Court to prevent a person from returning where the Court finds that the person voluntarily served, participated in or materially supported a listed terrorist organisation, would pose an unacceptable risk to Australians, and could not be safely managed by a less restrictive measure. ๐Ÿฎ. ๐—ฆ๐˜๐—ผ๐—ฝ ๐˜๐—ต๐—ฒ ๐—ฎ๐˜‚๐˜๐—ผ๐—บ๐—ฎ๐˜๐—ถ๐—ฐ ๐—ถ๐˜€๐˜€๐˜‚๐—ฒ ๐—ผ๐—ณ ๐—ฟ๐—ฒ๐˜๐˜‚๐—ฟ๐—ป ๐—ฝ๐—ฒ๐—ฟ๐—บ๐—ถ๐˜๐˜€ ๐˜„๐—ต๐—ถ๐—น๐—ฒ ๐˜๐—ต๐—ฒ ๐—–๐—ผ๐˜‚๐—ฟ๐˜ ๐—ฐ๐—ผ๐—ป๐˜€๐—ถ๐—ฑ๐—ฒ๐—ฟ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ฎ๐˜€๐—ฒ. The Ministerโ€™s obligation to issue or consider a return permit would be suspended while the application is prepared and determined. ๐Ÿฏ. ๐—ฆ๐˜๐—ฟ๐—ฒ๐—ป๐—ด๐˜๐—ต๐—ฒ๐—ป ๐—ฏ๐—ฎ๐—ถ๐—น ๐—น๐—ฎ๐˜„๐˜€ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ฒ๐—ฟ๐—ฟ๐—ผ๐—ฟ๐—ถ๐˜€๐—บ ๐—ผ๐—ณ๐—ณ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€. Community safety and national security would be the paramount considerations. Childcare, family circumstances, accommodation or electronic monitoring would not, by themselves, amount to exceptional circumstances justifying bail. ๐Ÿฐ. ๐—ฆ๐˜๐—ฟ๐—ฒ๐—ป๐—ด๐˜๐—ต๐—ฒ๐—ป ๐—ฝ๐—ฎ๐˜€๐˜€๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐˜€. The Minister could refuse, cancel or suspend a passport where a person is subject to an exclusion order or has been charged with or convicted of a terrorism offence. ๐Ÿฑ. ๐— ๐—ฎ๐—ธ๐—ฒ ๐—ถ๐˜ ๐—ฎ๐—ป ๐—ผ๐—ณ๐—ณ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐˜๐—ผ ๐—ผ๐—ฟ๐—ด๐—ฎ๐—ป๐—ถ๐˜€๐—ฒ ๐—ผ๐—ฟ ๐—ณ๐—ฎ๐—ฐ๐—ถ๐—น๐—ถ๐˜๐—ฎ๐˜๐—ฒ ๐—ฎ๐—ป ๐˜‚๐—ป๐—ฎ๐˜‚๐˜๐—ต๐—ผ๐—ฟ๐—ถ๐˜€๐—ฒ๐—ฑ ๐—ฟ๐—ฒ๐˜๐˜‚๐—ฟ๐—ป. A person who arranges the entry of a terrorist fighter without Commonwealth authority could face up to 10 years in prison. The Bill preserves judicial oversight. It enables the Minister and the Court to act on advice from Australiaโ€™s national security agencies. An exclusion order could remain in force for up to two years. Any further order would require a fresh application, updated national security advice and findings based on the risk at that time. One Nationโ€™s position is absolute. People who choose to serve a listed terrorist organisation like ISIS over Australia, and who remain an unacceptable risk to the Australian community, should not be allowed to return. Not with a permit. Not under surveillance. Not at all. Australians should not be forced to bear an unacceptable terrorism risk because Parliament and the Home Affairs Minister failed to act. We want to work constructively with the cross bench and other elected Members. We welcome any comments or proposed amendments that would strengthen the Bill or improve its operation. The safety of Australians should come first. I hope we can work together to close this gap in the law. #PaulineHanson #OneNation #ISIS #ProtectingAustralia #Government #Albo #Burke #Minister #AngusTaylor #AnthonyAlbanese #PrimeMinister #FireTheLiar

Pauline Hanson ๐Ÿ‡ฆ๐Ÿ‡บ

61,381 ๆฌก่ง‚็œ‹ โ€ข 2 ไธชๆœˆๅ‰

๐—ฉ๐—œ๐—–๐—ง๐—ข๐—ฅ ๐——๐—”๐—ฉ๐—œ๐—ฆ ๐—›๐—”๐—ก๐—ฆ๐—ข๐—ก: ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—–๐—ข๐—จ๐—Ÿ๐—— ๐—•๐—˜ ๐—ง๐—›๐—˜ ๐— ๐—ข๐—ฆ๐—ง ๐—š๐—˜๐—ข๐—ฃ๐—ข๐—Ÿ๐—œ๐—ง๐—œ๐—–๐—”๐—Ÿ๐—Ÿ๐—ฌ ๐—ฆ๐—œ๐—š๐—ก๐—œ๐—™๐—œ๐—–๐—”๐—ก๐—ง ๐—ฌ๐—˜๐—”๐—ฅ ๐—ฆ๐—œ๐—ก๐—–๐—˜ ๐—ช๐—ข๐—ฅ๐—Ÿ๐—— ๐—ช๐—”๐—ฅ ๐—œ๐—œ. VDH has been studying war and history for fifty years. When he speaks, it's worth listening carefully. His thesis: Donald Trump lit a fuse, and things are blowing up everywhere. Everyone is panicking, calling him a disruptor, a bull in a china shop. But step back and look at the full picture โ€” and you start to see something different. ๐—œ๐—ฅ๐—”๐—ก. Seven presidents in a row said they would prevent Iran from going nuclear. Seven presidents did nothing. The theocracy spent 47 years building proxy armies, funding terrorism, and accumulating the leverage to eventually hold the entire Middle East โ€” and then Europe, and then us โ€” at nuclear gunpoint. Trump bombed the nuclear facilities once. Iran kept rebuilding. Kept expanding its Russian and North Korean ballistic missile force. Kept proving that no deal, no negotiation, and no diplomatic framework was going to solve the problem. So Trump went back โ€” this time with the objective of either removing the theocracy entirely or rendering it permanently inert. That's where we are right now. ๐—ฉ๐—˜๐—ก๐—˜๐—ญ๐—จ๐—˜๐—Ÿ๐—”. Maduro is gone. A communist drug lord who propped up Cuba, spread Chavismo across Latin America, and shipped dangerous opiates into the United States โ€” removed. The new government has been told: put the oil on the world market, reform the economy, get the Chinese out, and you'll have a bright future. They're terrified of the United States. That's not a bug. That's the point. ๐—Ÿ๐—”๐—ง๐—œ๐—ก ๐—”๐— ๐—˜๐—ฅ๐—œ๐—–๐—” ๐—ฏ๐—ฟ๐—ผ๐—ฎ๐—ฑ๐—น๐˜†. Democratic revolutions in Central America. Argentina. Chile. Panama told to stop triangulating with China โ€” or lose the canal. They chose wisely. Result: China and Russia are being pushed out of the Western Hemisphere. Cuba is watching Venezuela and Iran and doing the math. No more Maduro oil. No more Russian subsidies. An economy too incompetent to survive on its own. Trump is 90 miles away and they know it. ๐—˜๐—จ๐—ฅ๐—ข๐—ฃ๐—˜ ๐—ฎ๐—ป๐—ฑ ๐—จ๐—ž๐—ฅ๐—”๐—œ๐—ก๐—˜. VDH makes a point the media consistently buries: Trump is the one who got rid of the Wagner Group. Trump gave offensive weapons to Ukraine. Trump warned about Nord Stream. Trump got out of the arms treaty. Not Biden. Not Obama. Trump. Now he's trying to thread an impossible needle โ€” weaken Putin enough that he stops expanding into Europe, while also preventing him from being so cornered that he becomes permanently dependent on China. That's not appeasement. That's grand strategy. ๐—ง๐—ต๐—ฒ ๐—ฝ๐—ผ๐—น๐—ถ๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฟ๐—ถ๐˜€๐—ธ ๐—ง๐—ฟ๐˜‚๐—บ๐—ฝ ๐˜๐—ผ๐—ผ๐—ธ. VDH makes a point almost nobody is making: Trump did not have to do this. The midterms are eight months away. The economy was recovering. Energy prices were low and he was bragging about them. A purely political animal does not โ€” right before midterms โ€” go into two of the world's largest oil producers and accept short-term energy disruption for long-term strategic gain. Europe was begging him not to. His own base was nervous. He did it anyway because he believed it was necessary. That's not politics. That's leadership. ๐—›๐—ฎ๐—ป๐˜€๐—ผ๐—ป'๐˜€ ๐—ฐ๐—ผ๐—ป๐—ฐ๐—น๐˜‚๐˜€๐—ถ๐—ผ๐—ป: If the United States ends 2026 having dismantled the Iranian theocracy, transformed Latin America, pushed China and Russia out of the Western Hemisphere, and resolved the Ukraine war on terms that don't reward aggression โ€” that achievement would make Reagan's defeat of the Soviet Union look modest by comparison. ๐˜š๐˜ต๐˜ณ๐˜ฆ๐˜ฏ๐˜จ๐˜ต๐˜ฉ ๐˜ณ๐˜ข๐˜ฅ๐˜ช๐˜ข๐˜ต๐˜ฆ๐˜ด ๐˜ง๐˜ณ๐˜ช๐˜ฆ๐˜ฏ๐˜ฅ๐˜ด๐˜ฉ๐˜ช๐˜ฑ. ๐˜ž๐˜ฆ๐˜ข๐˜ฌ๐˜ฏ๐˜ฆ๐˜ด๐˜ด ๐˜ณ๐˜ฆ๐˜ฑ๐˜ฆ๐˜ญ๐˜ด ๐˜ช๐˜ต. ๐—ช๐—ฎ๐˜๐—ฐ๐—ต ๐˜๐—ต๐—ฒ ๐—ณ๐˜‚๐—น๐—น ๐—ฉ๐——๐—› ๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€. ๐—œ๐˜'๐˜€ ๐˜๐—ต๐—ฒ ๐—ฏ๐—ฒ๐˜€๐˜ ๐Ÿญ๐Ÿฌ ๐—บ๐—ถ๐—ป๐˜‚๐˜๐—ฒ๐˜€ ๐—ผ๐—ณ ๐—ด๐—ฒ๐—ผ๐—ฝ๐—ผ๐—น๐—ถ๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ ๐˜†๐—ผ๐˜‚'๐—น๐—น ๐˜€๐—ฒ๐—ฒ ๐˜๐—ต๐—ถ๐˜€ ๐˜„๐—ฒ๐—ฒ๐—ธ.

M.A. Rothman

133,616 ๆฌก่ง‚็œ‹ โ€ข 6 ไธชๆœˆๅ‰

$NWBO #๐——๐—–๐—ฉ๐—ฎ๐˜…-๐—Ÿ: ๐—ง๐—ต๐—ฒ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—ฃ๐—น๐—ฎ๐—ถ๐—ป ๐—ง๐—ฒ๐—ฟ๐—บ๐˜€ A short, plain-language reading of the survival evidence for DCVax-L in #glioblastoma, and what it means under the MHRAgovuk guideline on external control arms. ๐Ÿ“Š ๐—ฃ๐—”๐—ฅ๐—ง ๐—ข๐—ก๐—˜: ๐—ช๐—›๐—”๐—ง ๐—ง๐—›๐—˜ ๐—ง๐—ฅ๐—œ๐—”๐—Ÿ ๐—™๐—ข๐—จ๐—ก๐——, ๐—”๐—ก๐—— ๐—ช๐—›๐—ฌ ๐—œ๐—ง ๐— ๐—”๐—ง๐—ง๐—˜๐—ฅ๐—ฆ DCVax-L more than doubled five-year survival, and the benefit is durability: a subset gets lasting disease control and simply stays alive. ๐Ÿ’‰ ๐—ช๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ถ๐˜€ DCVax-L is a personalized cancer vaccine for glioblastoma, the deadliest form of brain cancer and a designated orphan disease. It is a living drug: its active ingredient is the patient's own immune cells, primed with proteins from that patient's surgically removed tumor, so the immune system learns to attack the cancer. Unlike a chemical drug that is metabolized and cleared, it switches on a living immune response that keeps working long after the injection. Glioblastoma comes back in almost everyone: even with the full standard of surgery, radiation, and temozolomide chemotherapy, most patients live under two years, and only about one in twenty reaches five. DCVax-L is given on top of that standard care, not in place of it: every patient in the trial received surgery, radiation, and temozolomide, and the vaccine was added to it, so the comparison measures what the vaccine adds. For two decades, nearly every new drug tried in this disease has failed. That is the backdrop against which any positive result must be judged. ๐Ÿ“ˆ ๐—ช๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ณ๐—ผ๐˜‚๐—ป๐—ฑ In a Phase 3 trial of 331 patients, those who received DCVax-L lived longer. At the median the gain looks modest, about three months (19.3 versus 16.5). The number that matters sits at the far end of the survival curve: more than twice as many vaccine patients were alive at five years, 13.0% versus 5.7%, and a few reached ten years in a disease that usually kills within three. In patients whose tumor had already returned, the effect was larger still, cutting the risk of death by about 42%. ๐Ÿ‘ฅ ๐—˜๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ด๐—ฟ๐—ผ๐˜‚๐—ฝ ๐—ฏ๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜๐—ฒ๐—ฑ, ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐˜๐—ต๐—ฒ ๐—ต๐—ฎ๐—ฟ๐—ฑ๐—ฒ๐˜€๐˜ ๐˜๐—ผ ๐˜๐—ฟ๐—ฒ๐—ฎ๐˜ The benefit was not confined to the easy cases. Of the six prespecified subgroups the trial examined, every single one favored DCVax-L, and there was no group in which it did worse than standard care. The largest gains came in patients whose tumors carry MGMT methylation, who reached a median survival of 30.2 months from randomization against 21.3 for the controls. But even the hardest-to-treat patients, whose tumors lack that methylation, resist standard chemotherapy, and carry the worst prognosis in this disease, still came out ahead with the vaccine, at a hazard ratio of 0.93. A treatment that helps across the whole population, and helps most where the biology is most favorable, is acting like a real drug. ๐Ÿ“‰ ๐—ช๐—ต๐˜† ๐˜๐—ต๐—ฒ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐—ป ๐—ต๐—ถ๐—ฑ๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—น ๐˜€๐˜๐—ผ๐—ฟ๐˜† That five-year number is the whole story, and the median buries it. Almost every treatment that ever helped in glioblastoma did the same modest thing: it slid the survival curve a few months to the right, then let it fall back. Doubling five-year survival is different in kind. A three-month gain at the median cannot, by itself, double the fraction alive at five years. The only shape that produces both numbers is a split: most patients get the small delay the median measures, while a subset gets durable disease control that lasts for years, well past where glioblastoma should have ended them. That subset is the long tail of the curve, and it is where the benefit lives. A median ignores extremes, the way a town's median income tells you nothing about its millionaires. The real story is not a longer delay; it is that a meaningful share of patients simply stay alive. ๐Ÿงฌ ๐—ช๐—ต๐˜† ๐˜๐—ต๐—ฒ ๐—ฏ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฝ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐˜๐˜€ ๐˜๐—ต๐—ถ๐˜€ ๐˜€๐—ต๐—ฎ๐—ฝ๐—ฒ The tail is not luck. It is what this biology is built to produce. The vaccine carries proteins from the patient's own tumor, so it aims the immune system at whatever that tumor is made of, not a fixed short list of targets. And it amplifies: one trained immune cell drives many others that multiply into cancer-killers. Andres Salazar, the neurologist who developed poly-ICLC into the clinical adjuvant given with the vaccine, puts it in a line: you start the fire, and you keep it burning. A response like that does not produce a one-time bump. It builds and widens over time. What matters is not just that a response forms, but what kind. Dendritic cells are the immune system's master switch for that, the cells that set what kind of attack the body mounts, and this vaccine is built from them. It drives what immunologists call a type 1 polarized response: an interferon-driven, cytotoxic program aimed squarely at the tumor. That direction comes from the vaccine itself; the poly-ICLC adjuvant given with it drives the same interferon program and sustains it. That is the active ingredient, and it has been measured. In UCLA studies of this approach, the patients whose immune systems mounted the strongest interferon response lived the longest. The response also spreads. In a different cancer, a vaccine carried on this same poly-ICLC adjuvant drove more than 70% of a patient's cancer-killing T cells to target proteins that were never in the vaccine: the immune system outgrew its original targets and went after the rest of the tumor on its own. This is called epitope spreading, and it is not particular to one tumor; it is what this kind of response does, and it is the kind of response DCVax-L builds. That breadth is the likeliest thing separating the long-term survivors from everyone else, a response that breaks past its targets and clears the disease rather than one that stays caged and stops. There is even a tell in who benefits most: the effect is largest in tumors whose biology builds up more mutations under chemotherapy, and more mutations mean more targets for a whole-tumor vaccine to find. The same logic explains what the vaccine is not, and what it does not need. Checkpoint inhibitors, the drugs that release the immune system's brakes, have failed on their own in glioblastoma because there was no active response to release; the vaccine supplies that response first. That makes the vaccine the natural foundation for combination therapy. Combining it with its poly-ICLC adjuvant, made by Oncovir, has already shown meaningful survival gains in a published analysis. In the pivotal trial, the vaccine's proven benefit came added on top of standard chemotherapy and radiation; the newer question is how much the immune response can carry on its own. A UCLA trial is now testing that in patients whose tumors have returned, adding #Keytruda (pembrolizumab), the checkpoint antibody from $MRK, in a regimen built entirely around the immune response with no chemotherapy or radiation in it at all. Its interim survival curve shows the shape the biology predicts. In the arm given the vaccine and Keytruda together after surgery, the curve does not fall away but flattens into a plateau, with roughly 65% of patients still alive well past the point where recurrent glioblastoma kills nearly everyone. That plateau is the signature of a response that took hold and lasted, the type 1 attack forming durable immune memory so that once the disease is controlled it stays controlled. That is where this points, and where it is already arriving, a treatment that works through the response itself, one that could in time lean less on the harsh radiation and chemotherapy that have defined glioblastoma care and barely moved its survival. These are interim results, from Prins, Cloughesy, and Liau at UCLA. ๐Ÿ” ๐—ฃ๐—”๐—ฅ๐—ง ๐—ง๐—ช๐—ข: ๐—œ๐—ฆ ๐—œ๐—ง ๐—ฅ๐—˜๐—”๐—Ÿ? The trial was randomized, an independent experiment shows the outside comparison is trustworthy, and every separate check points the same way. ๐Ÿค” ๐—ง๐—ต๐—ฒ ๐—ผ๐—ฏ๐—ท๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป, ๐—ฎ๐—ป๐—ฑ ๐˜„๐—ต๐˜† ๐—ถ๐˜ ๐—บ๐—ถ๐˜€๐˜€๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ธ So much for what happened; the harder question is whether to believe it. The trial has the feature critics attacked: it could not keep a normal placebo group, because patients assigned to placebo were allowed, by design and by medical ethics, to switch to the vaccine once their cancer returned, and almost all did. That erased the internal comparison, so survival was measured against closely matched patients from other completed trials, an approach called an external control, which critics argued could tilt toward the vaccine. What the objection misses is where the randomization went. This was a randomized, blinded trial. The patients who got the vaccine were assigned to it at random, not hand-picked, so the treated group is an ordinary slice of the trial population, not a favorable one. The crossover removed the placebo group but never touched how patients were assigned. That leaves exactly one place for bias to enter, the outside comparison group, which is precisely what the next checks test. โœ… ๐—ง๐—ต๐—ฒ ๐—ฐ๐—ต๐—ฒ๐—ฐ๐—ธ ๐˜๐—ต๐—ฎ๐˜ ๐—บ๐—ฎ๐—ธ๐—ฒ๐˜€ ๐—ถ๐˜ ๐˜๐—ฟ๐˜‚๐˜€๐˜๐˜„๐—ผ๐—ฟ๐˜๐—ต๐˜† Before trusting a scale to weigh something unknown, you confirm it reads zero with nothing on it. That is what the calibration does, and it is the strongest part of the case. A separate, independent randomized trial called INSIGhT was run through the very same external-control method, and it gave two answers. First, three experimental drugs that had already failed were run through it, and it correctly found nothing (hazard ratios of 1.00, 0.93, and 0.88): the method does not manufacture a benefit where none exists. Second, INSIGhT's external controls were set head to head against its own randomized internal controls, and they were statistically indistinguishable. In this disease, an external control reproduces the answer a real randomized control would have given, and because that trial belonged to a different group, no one can say a sponsor graded its own work. The one place bias could enter, the control side, is the one place an independent randomized experiment certified as clean. There is a deeper fit worth naming, and it is what makes the two halves of this case one. The same instrument that reported those three failures as failures reads the vaccine as a success, and the biology says why: those drugs could not hold a tumor this varied, and the vaccine builds the broad, lasting response that finally does. One method, opposite readings, and one mechanism behind both. The statistics and the biology are not two arguments. They are the same argument seen twice. ๐Ÿƒ ๐—ช๐—ฎ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ฟ๐—ถ๐˜€๐—ผ๐—ป ๐˜€๐˜๐—ฎ๐—ฐ๐—ธ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐˜ƒ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ'๐˜€ ๐—ณ๐—ฎ๐˜ƒ๐—ผ๐—ฟ? A natural worry is that the outside comparison was arranged after the fact to flatter the vaccine. The trial was built to prevent that. The patients to compare against, and the rules for matching them, were fixed in writing before anyone saw results, and an independent firm, not the company, chose the comparison trials against those rules. The trial also switched its main measure partway through, from delaying tumor growth to overall survival, but that was not a maneuver: immune treatments cause a harmless swelling that mimics tumor growth on scans and made the growth measure unreliable, and the switch was made while everyone was still blinded. Three further checks point the same way. Survival in this disease has not improved over the years the comparison spans, so same-era controls are sound. When the borrowed controls were tested directly, the comparison came out conservative rather than flattering. And the controls were counted from the same point in the disease as the vaccine patients, so neither side got a head start. Where the comparison can err, it errs against the drug. ๐Ÿ”ฌ ๐—ง๐—ต๐—ฒ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—ฐ๐—ฎ๐—ฟ๐—ฒ๐—ณ๐˜‚๐—น ๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ ๐—บ๐—ฎ๐—ฑ๐—ฒ ๐˜๐—ต๐—ฒ ๐—ฏ๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜ ๐—ฏ๐—ถ๐—ด๐—ด๐—ฒ๐—ฟ, ๐—ป๐—ผ๐˜ ๐˜€๐—บ๐—ฎ๐—น๐—น๐—ฒ๐—ฟ The first comparison used whole groups. A sharper one became possible once patient-level records from three other trials could be obtained, pairing each vaccine patient with controls matched on the traits that drive survival in glioblastoma, above all MGMT methylation status, matched exactly, plus age, sex, extent of surgery, residual disease, and performance status. When the comparison got sharper, the benefit grew in every one of these analyses. The original cohort-level estimate was 2.8 months. Patient-level matching across the three trials put the gain between 3.4 and 6.3 months, and a method that weights patients rather than pairing them put it between 3.4 and 4.3, with several of the matched comparisons roughly doubling the original figure. The hazard ratio moved the same way, from 0.80 to between 0.69 and 0.77. The direction matters. A real effect blurred by crude matching gets clearer when the matching improves, while a biased one tends to shrink. It got stronger. ๐Ÿ•ต๏ธ ๐—›๐—ผ๐˜„ ๐—บ๐˜‚๐—ฐ๐—ต ๐—ต๐—ถ๐—ฑ๐—ฑ๐—ฒ๐—ป ๐—ฏ๐—ถ๐—ฎ๐˜€ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ ๐—ถ๐˜ ๐˜๐—ฎ๐—ธ๐—ฒ ๐˜๐—ผ ๐—ฒ๐˜…๐—ฝ๐—น๐—ฎ๐—ถ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฎ๐˜„๐—ฎ๐˜† A fair question is how much hidden bias it would take to erase the result. Statisticians measure that with the E-value, and here a hidden factor would have to be about as strong as age is on survival, would also have to drive who received the vaccine, and would have to have escaped the decades of research that mapped every known risk factor in this disease. A second, independent check, Rosenbaum's Gamma, comes at it from the other side, asking how large an unseen imbalance between matched patients it would take to break the result, and it reaches the same verdict. Every factor strong enough to matter was already matched. A hidden one that clears that bar is not plausible. ๐Ÿ”’ ๐—ช๐—ต๐˜† ๐˜๐—ต๐—ฒ ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜ ๐—ถ๐˜€ ๐—ต๐—ฎ๐—ฟ๐—ฑ ๐˜๐—ผ ๐—ณ๐—ฎ๐—ธ๐—ฒ The strongest point is not any single result. It is that a hidden bias big enough to explain the effect away would have to produce the same answer in every independent test at once: โ€ข The independent randomized calibration trial. โ€ข Three separate comparison trials, drawn from different studies. โ€ข Two different statistical methods that handle the data in different ways. โ€ข A separate pooled analysis of other dendritic-cell vaccine trials. โ€ข The internal math of the survival curve, which points to the same result (about 0.71 at five years) that the patient matching found. And it would have to fall in the exact direction the biology predicted before any data existed: a slow, widening benefit concentrated in long-term survivors. A single hidden factor that could forge all of that at once is not a hidden factor. It is a coincidence that does not happen. ๐Ÿฉบ ๐—ฃ๐—”๐—ฅ๐—ง ๐—ง๐—›๐—ฅ๐—˜๐—˜: ๐—ช๐—›๐—”๐—ง ๐—œ๐—ง ๐— ๐—˜๐—”๐—ก๐—ฆ The drug is nearly free of harm, the evidence fits an established and approved regulatory path, and what remains unrun changes nothing about the case. ๐Ÿ›ก๏ธ ๐—ง๐—ต๐—ฒ ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜† Two things decide whether a real effect reaches patients: whether the drug is safe enough to use, and whether regulators will accept the evidence. The first is settled. Across 2,151 doses, only five serious side effects were even possibly related to the vaccine, with no autoimmunity and no cytokine storm. It is made once, in about eight days, then stored and given as a simple injection. When a treatment barely harms, the benefit needed to justify it falls, and the benefit here clears that lower bar easily. โณ ๐—ช๐—ต๐˜† ๐˜๐—ต๐—ฒ ๐˜€๐˜๐—ฟ๐—ผ๐—ป๐—ด๐—ฒ๐—ฟ ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ฎ๐—ฝ๐—ฝ๐—ฒ๐—ฎ๐—ฟ๐—ฒ๐—ฑ ๐—ผ๐—ป๐—น๐˜† ๐—ป๐—ผ๐˜„ A reasonable person asks why the sharper analysis appeared in 2026 and not in 2023. The answer is access, not choice. The patient-level analysis was written into the trial's plan from the start, to run if and when the data could be obtained. The company tried and could not get it in 2023, because the trials that held it had not released it; it became available later through a data-sharing repository, on the data owners' timeline, not the company's. The stronger analysis was always the plan. It was waiting on data that other parties control. ๐Ÿ”„ ๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐˜„๐—ต๐—ผ๐˜€๐—ฒ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฟ๐—ฒ๐˜๐˜‚๐—ฟ๐—ป๐—ฒ๐—ฑ ๐—ฎ๐—น๐˜€๐—ผ ๐—ฏ๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜๐—ฒ๐—ฑ The vaccine helped not only newly diagnosed patients but also those whose tumor had already come back, and there the effect was the largest seen anywhere in the trial. In that group, median survival ran 13.2 months from recurrence against 7.8 for the controls. The separation opened immediately, with 90.6% of vaccine patients alive at six months against 64.0% of controls, and the lead held to the later marks, where survival more than doubled: 20.7% against 9.6% at two years, 11.1% against 5.1% at two and a half. These are the original cohort-level results, already published. The high-resolution patient-level matching that was applied to the newly diagnosed group has not yet been done here, for a practical reason: it needs patient records from other recurrent-cancer trials, held by a European research organization that shares them through its own formal request. Obtaining them is a routine next step, not an obstacle, and the newly diagnosed experience suggests the sharper analysis would only make the recurrent result stronger. The approval case rests on the newly diagnosed evidence, so nothing important depends on this step; it would simply sharpen a result that is already the strongest in the trial. ๐Ÿ›๏ธ ๐—ช๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ถ๐˜€ ๐—บ๐—ฒ๐—ฎ๐—ป๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฎ๐—น Regulators do not treat an external control as a first choice, but the MHRA's guideline allows it in exactly this situation: a severe disease where a placebo trial is not ethical or feasible, and an effect large enough to interpret despite the design. The guideline even gives its own worked example of an acceptable external control, and it reads almost like a description of this trial: a rare disease, no ethical placebo, same-era standard-of-care controls, an objective survival endpoint, and an effect too large to blame on bias. DCVax-L fits on every count, and it was the first medicine ever to receive the MHRA's Promising Innovative Medicine designation, which asks essentially the same questions. The newly diagnosed case carries the decision on its own evidence, and regulators weigh that evidence against the disease it treats: in a cancer this lethal, with nothing better on offer, the question is whether the benefit is large, clear, and consistent enough to act on, and a benefit of this size, pointing the same way from every direction, is. ๐Ÿ“œ ๐—ง๐—ต๐—ถ๐˜€ ๐—ต๐—ฎ๐˜€ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฑ๐—ผ๐—ป๐—ฒ ๐—ฏ๐—ฒ๐—ณ๐—ผ๐—ฟ๐—ฒ, ๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฒ๐—ฑ External controls are not a novelty invented for this drug. Over the past two decades they have factored into roughly forty-five drug approvals by the United States regulator, each granted under the conditions that apply here: a serious or rare disease, a placebo that would be unethical, and high unmet need. Regulators do not grant this lightly. They grant it when the disease is serious, its course is predictable and objectively measured, and the effect is large. Glioblastoma meets all three. The named cases cover every part of this disease's profile. Defibrotide, for a life-threatening transplant complication, was approved on a propensity-score comparison to a historical control, the same kind of method used here. Blinatumomab, for an aggressive relapsed leukemia, is the precedent for a fast-killing cancer, cleared by both the United States and European regulators. Cerliponase alfa is the precedent for a fatal brain disease, cleared by both agencies on treated patients versus a matched natural-history group. Glioblastoma is both at once, a fast-killing cancer of the brain, read by the same method, so no part of its profile lacks a close approved precedent. And on the one axis that governs how far an external-control result can be trusted, DCVax-L goes beyond all three. Each of those drugs was tested in a single-arm trial, with no randomization at all. DCVax-L began as a randomized trial and became an external-control comparison only when ethics consumed its placebo group. It sits in that tradition, and at the top of it. ๐ŸŽฏ ๐—ง๐—ต๐—ฒ ๐—ฏ๐—ผ๐˜๐˜๐—ผ๐—บ ๐—น๐—ถ๐—ป๐—ฒ This began as a randomized trial. Medical ethics forced it into an external-control comparison. Every independent way of checking it, on different data and different math, points the same direction, and the biology predicted that direction in advance. The first analysis did not overstate the vaccine's effect. Read with the right tools, it understated it.

Andrew Caravello, DO

11,406 ๆฌก่ง‚็œ‹ โ€ข 3 ไธชๆœˆๅ‰

Dear Linda, This is my rebuttal to your analysis of Pierre and last nightโ€™s leadership review from your substack article. I even added a video to remind you of why Pierre's is still the right choice as leader of the opposition to deal with fiscally irresponsible Liberals in 2026. Youโ€™re arguing Linda, that the party should dump the one leader who exposed repeatedly and pushed Justin Trudeau out and expanded the Conservative base. Weโ€™ve debated this before, and youโ€™ve already conceded several points about Pierreโ€™s effectiveness and actual popularity. I hope youโ€™ll read this reply with that same honesty as when we spoke in spaces. ๐—ช๐—ต๐—ฒ๐—ป ๐—ฎ ๐—น๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐˜€ ๐—ฎ ๐—น๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ ๐—ฟ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐˜„๐—ถ๐˜๐—ต ๐Ÿด๐Ÿณ.๐Ÿฐ ๐—ฝ๐—ฒ๐—ฟ๐—ฐ๐—ฒ๐—ป๐˜ ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฎ๐—ป๐—ฑ ๐—ฟ๐—ฒ๐—ฐ๐—ผ๐—ฟ๐—ฑ ๐˜๐˜‚๐—ฟ๐—ป๐—ผ๐˜‚๐˜, ๐—ฐ๐—ฎ๐—น๐—น๐—ถ๐—ป๐—ด ๐—ถ๐˜ ๐—ฎ โ€œ๐—ฐ๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ปโ€ ๐—ผ๐—ณ ๐—ฎ โ€œ๐—น๐—ผ๐˜€๐—ฒ๐—ฟโ€ ๐—ฑ๐—ผ๐—ฒ๐˜€๐—ปโ€™๐˜ ๐—ฎ๐—ฑ๐—ฑ ๐˜‚๐—ฝ. ๐—œ๐—ณ ๐˜๐—ต๐—ฎ๐˜โ€™๐˜€ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ, ๐˜„๐—ฒโ€™๐—ฟ๐—ฒ ๐—ป๐—ผ๐˜ ๐˜‚๐˜€๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐˜€๐—ฎ๐—บ๐—ฒ ๐—บ๐—ฎ๐˜๐—ต. You say Pierreโ€™s hiding in safe ridings and managed contests. The numbers say otherwise. ๐—›๐—ถ๐˜€ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐—น ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ถ๐˜€ ๐˜€๐˜๐—ฟ๐—ผ๐—ป๐—ด๐—ฒ๐—ฟ ๐˜๐—ต๐—ฎ๐—ป ๐˜„๐—ต๐—ฎ๐˜ ๐—ฆ๐˜๐—ฒ๐—ฝ๐—ต๐—ฒ๐—ป ๐—›๐—ฎ๐—ฟ๐—ฝ๐—ฒ๐—ฟ ๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ถ๐˜ƒ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐Ÿฎ๐Ÿฌ๐Ÿฌ๐Ÿฑ. You also frame Pierre as a โ€œknown quantityโ€ no one wants, even though heโ€™s driving engagement levels the party hasnโ€™t seen in decades. At some point, dismissing popularity starts sounding like frustration with voters, not leadership analysis IMHO. Youโ€™re convinced Mark Carney has already passed Pierre. Yet despite high personal approval, his partyโ€™s still neck and neck with the Conservatives. If flexibility is such a strength, why hasnโ€™t it translated into real momentum creating a huge gap between the parties? That's a question that requires an honest deliberation Pierre isnโ€™t avoiding fights. Heโ€™s staying focused while food prices are set to climb again this year, costing families hundreds more. Youโ€™re worried Pierre doesnโ€™t look prime ministerial enough abroad. But last I checked leadership isnโ€™t mainly about decoration Linda. While youโ€™re focused on optics, heโ€™s talking about an energy corridor and cutting the GST on new homes so the economy actually works. Fancy credentials donโ€™t win trade wars. Production does. A country that canโ€™t build anything has no leverage, no matter how polished its leader looks like or what he studied. The โ€œcult of personalityโ€ you complain about is really people who are done being told that looks matter more than results, even though Pierre by every metric I use in my industry of Marketing and Advertising he checks off. But more importantly than all that, there is a glaring issue that image will not placate...Over two million Canadians use food banks every month. At that point, image stops being persuasive wouldn't you think? Pierreโ€™s saying the uncomfortable part out loud, that's the problem. As I already told another recently, that's the issue Socrates outlined as the problem with democracy. People want candy... Not medecine when they are sick. Canadaโ€™s heading toward a fiscal cliff with massive new borrowing planned, when it was borrowing that got us into this mess when Trudeau borrowed close to $700B and doubled the national debt seemingly overnight. You think next year will be tough for him? Really? Itโ€™ll be tougher for Canadians who were told branding could replace basic math. Pierre has been consistent about the uncontrolled spending of the last 5 years, while Liberals seem to double down. History is crying in the corner after screaming for centuries that once the shine wears off a carefully packaged leader, people look for the one who told the truth when it wasnโ€™t popular. Presentation doesnโ€™t fix structural damage Linda. This isnโ€™t about Pierre. Itโ€™s about whether we keep choosing comfort over correction. Eventually, the pain forces the issue. When that happens, no one cares what the doctor looks like. They care whether the problem gets fixed. Vesper

Vesper

23,796 ๆฌก่ง‚็œ‹ โ€ข 8 ไธชๆœˆๅ‰